1
EXHIBIT 13
THE GILLETTE COMPANY
Founded in 1901, The Gillette Company is the world leader in male grooming, a
category that includes blades, razors and shaving preparations. Gillette also
holds the number one position worldwide in selected female grooming products,
such as wet shaving products and hair epilation devices. The Company is the
world's top seller of writing instruments and correction products, toothbrushes
and oral care appliances. In addition, the Company is the world leader in
alkaline batteries.
Gillette manufacturing operations are conducted at 62 facilities in 25
countries, and products are distributed through wholesalers, retailers and
agents in over 200 countries and territories.
CONTENTS
FINANCIAL HIGHLIGHTS 1
MISSION AND VALUES 2
LETTER TO STOCKHOLDERS 3
REVIEW OF OPERATIONS 6
MANAGEMENT'S DISCUSSION 18
FINANCIAL STATEMENTS 24
HISTORICAL FINANCIAL SUMMARY 41
PRINCIPAL DIVISIONS AND SUBSIDIARIES 42
DIRECTORS AND OFFICERS 44
CORPORATE AND STOCKHOLDER INFORMATION 45
2
BLADES &
RAZORS
BUSINESS SEGMENT SALES
$ Millions
----------
94 2351
95 2635
96 2836
97 2881
98 3028
Extending a remarkable record of achievement, Gillette again strengthened its
clear global leadership in blades and razors, its principal line of business.
Sales registered good progress in 1998. Profits were marginally lower,
reflecting spending to support the introduction of the revolutionary Mach3
shaving system.
Offering the first major blade edge innovation in 30 years, the Mach3 is
the only shaving system to feature three progressively aligned and independently
suspended blades to provide a closer shave in fewer strokes with less
irritation.
Since its introduction in June in North America and in September in Western
Europe, the Mach3 system has proven itself the most successful blade product
ever sold. It has surpassed every market performance measure the Company has
established, with sales and share growth increasing at a rate well ahead of the
record set by the Sensor system in its debut in 1990.
By year-end, the Mach3 shaving system was the best-selling blade and razor
in every country in which it was sold. In the United States, the Gillette share
of the blade market soared to its highest level in nearly 40 years.
Plans call for distribution of the Mach3 system to be extended to all major
markets worldwide in 1999.
As expected, the Mach3 system drew sales from other Gillette blades and
razors, although the decline in those sales was much less than the Mach3
system's sales contribution.
The Sensor family of shaving systems, the Company's previous technological
standard-bearer, generated sales above $1 billion for the fourth consecutive
year. Both the SensorExcel and Sensor shaving systems retained leading share
positions in many countries. The SensorExcel for Women shaving system
substantially increased its share of market in North America and Western Europe,
while posting exceptional sales progress in its newer markets of Latin America
and Eastern Europe.
Although sales weakened, the Atra and Trac II shaving systems maintained
important share positions in 1998, more than 20 years after their introductions.
Gillette disposable razor sales rose moderately, fueled by the strong
growth of CustomPlus razors, especially in Latin America, where they are sold
under the Prestobarba Max name. Much higher sales of the Agility women's
disposable razor also contributed to the gain. Gillette disposable razors
remained the clear market leaders worldwide, with the Good News brand the top
seller in the United States for the 23rd year in a row.
The double edge blade market continued to decline. Gillette sales fell
sharply, but the Company retained its longtime world leadership position.
Underlying its history of unparalleled success in the blade and razor
market, the Company's commitment to technological innovation and excellence will
remain the wellspring of outstanding growth prospects in the years ahead.
[PHOTOGRAPH OF GILLETTE RAZORS]
The Mach3 shaving system
PAGE 6
3
SensorExcel Sensor
for Women Excel
Gillette MACH 3
[PHOTOGRAPH OF GILLETTE MACH 3 RAZOR]
ContourPlus
Sensor Gillette
for Women Agility
4
Gillette
Series RIGHT
GUARD
Gillette
for Women
Satin Care
[PHOTOGRAPH OF GILLETTE FOR WOMEN SATIN CARE SHAVE GEL]
SOFT Dry
&DRI Idea
5
TOILETRIES
BUSINESS SEGMENT SALES
$ Millions
----------
94 1162
95 1236
96 1375
97 1410
98 1214
Jafra Sales
Sales and profits of the Company's toiletries business were substantially below
those of 1997, due in large part to the divestiture of the Jafra skin care and
cosmetics business in April 1998. Profits also were reduced by investment
spending to support the international rollout of the Gillette Series and Satin
Care brands.
Worldwide sales of deodorants/antiperspirants, the largest Gillette
toiletries category, recorded a slight decrease. In the United States, where the
Company's well-established deodorant/antiperspirant brands remained among the
leaders, technologically innovative clear stick versions of the Right Guard and
Gillette Series brands were the top performers, generating sales well above
those of the year before.
International deodorant/antiperspirant sales showed little change, as
considerable growth throughout Western Europe and the Middle East, primarily
reflecting brisk demand for the Gillette Series brand, was offset by weaker
sales in other regions. During the year, Satin Care deodorants/antiperspirants
for women were introduced in selected markets in Eastern Europe and Latin
America. Consumer response in both areas was quite favorable.
Paced by sizable advances in Western Europe, worldwide sales of Gillette
shave preparations rose moderately. This was chiefly attributable to the
Gillette Series brand, which posted notably higher sales in established markets
and was well-received in a number of introductory markets.
Another contributor was popular Satin Care for Women soap-free shaving gel,
whose nonaerosol form in an innovative soft touch bottle has generated strong
demand.
Reflecting these gains, Gillette brands improved their share in the United
States and many key markets abroad. This progress enabled the Company to
strengthen further its leading position in the global shave preparations
business.
Worldwide sales of Gillette after-shaves declined significantly, due
principally to shortfalls in international markets. The Company's shower gels,
sold primarily under the Gillette Series name, also recorded notably lower
sales.
In the hair care products category, the White Rain brand registered a
sizable decrease in sales. Gillette is exploring the possible sale of this
brand. Although White Rain is the third largest hair care brand in the United
States, it is not a global brand, nor is hair care one of the Company's core
product categories.
Supported by technologically innovative products, marketed with an
increasingly strong global perspective, the Company's tightly focused toiletries
business has a sound basis for future growth.
[PHOTOGRAPH OF GILLETTE SHAVING GELS AND DEODORANTS]
Satin Care for Women shaving gels
PAGE 9
6
STATIONERY
PRODUCTS
BUSINESS SEGMENT SALES
$ Millions
----------
94 807
95 862
96 915
97 924
98 856
The steady growth that has long characterized the Gillette stationery products
business was interrupted in 1998. Sales were well below those of the previous
year, and profits decreased significantly. These results were due primarily to
substantially lower sales of Parker writing instruments, chiefly related to
economic weakness in the Asia-Pacific region. Nonetheless, the Company retained
its standing as the worldwide leader in the highly competitive writing
instruments and correction products businesses.
With its well-established Paper Mate, Parker and Waterman franchises,
Gillette holds a strong position within all writing systems, price levels,
distribution channels and geographic areas.
Paper Mate writing instruments are the largest franchise in the Company's
stationery products business. Paced by advances in the United States and Western
Europe, worldwide Paper Mate sales climbed moderately, with a broad array of
writing instruments contributing.
In the low-priced category, which recorded higher sales, the strongest
gains were generated by the Comfort Mate stick ball pen. A retractable model,
introduced in the United States during the year, also was well-received.
Mid-priced Paper Mate pens achieved good sales progress worldwide. Sales of
the Flexgrip family of refillable pens moved well above those of the year
before. Dynagrip pens, led by continued brisk demand for the disposable
Dynagrip, posted a sizable gain in sales, as did Eraser Mate erasable ink pens.
At year-end, the Company introduced the Paper Mate Gel-Roller ball pen,
featuring a spring-loaded point and technologically advanced Gel-Glide ink for
superior writing performance. Initial trade and consumer response has been very
positive.
Worldwide sales of Parker writing instruments declined significantly. New
products planned for 1999, together with broadened distribution, are expected to
revitalize this well-respected brand.
Waterman writing instruments recorded somewhat lower sales, as a good
showing in the United States was unable to offset weaker sales abroad. In the
important prestige segment, the Waterman Carene fountain pen turned in a strong
sales performance in the United States and several major international markets.
Sales of Liquid Paper correction products were below those of 1997. This
reflected a substantial shortfall in sales of Liquid Paper correction fluids,
which retained their longtime position as the worldwide market leader. Liquid
Paper correction pen sales matched the prior year's record, while sales of
Liquid Paper DryLine correction films climbed sharply, fueled by sustained
demand for disposable films.
Strategies for growth in stationery products will center on further
developing this business area's strong combination of superior products,
powerful brand names and an expanding global presence.
[PHOTOGRAPH OF GILLETE STATIONERY PRODUCTS]
The Paper Mate Gel-Roller pen
PAGE 10
7
FLEXGRIPultra
PARKER Liquid
PAPER MATE Paper
Gel-Roller
[PHOTOGRAPH OF THE PAPER MATE GEL-ROLLER PEN]
DYNAGRIP WATERMAN
8
BRAUN ThermoScan
Flex Integral ultra speed
Braun Oral-B Plaque Remover
[PHOTOGRAPH OF BRAUN ORAL-B PLAQUE REMOVER]
AromaSelect
Shave & Shape
9
BRAUN
BUSINESS SEGMENT SALES
$ Millions
----------
94 1348
95 1621
96 1773
97 1744
98 1740
Braun sales showed little change in 1998, as good progress in North America and
Western Europe was offset by the negative effects of a severe economic downturn
in other key regions. Profits were somewhat below the previous year's record
level.
Although sales of men's electric shavers were considerably lower, Braun
remained a leader in the worldwide market. This position was well-supported by
the Flex Integral family of pivoting head shavers, which registered unit volume
growth well above that of the year before.
The principal contributor to this advance was the top-of-the-line Flex
Integral ultra speed shaver. Excellent consumer acceptance of this premium
shaver enabled Braun to improve its sizable share positions in several major
markets. Consumers also responded positively to moderately priced Flex Integral
shavers in attractive colors with youthful appeal.
The Braun Silk-epil family of electric hair epilators for women was
strengthened by the launch in early 1998 of the Silk-epil SuperSoft brand.
Offering more comfortable hair removal, this premium epilator helped Braun
maintain its global market leadership.
The strong momentum of Braun's oral care appliance business accelerated in
1998, driven chiefly by the continued resounding success of Braun Oral-B plaque
removers.
The latest addition to this line, the Braun Oral-B 3D plaque remover, was
introduced at midyear in North America and Western Europe. Utilizing
breakthrough technology, the new plaque remover provides a unique
three-dimensional brushing action that combines two distinct motions -- rapid
pulsation to loosen plaque and rapid oscillation to sweep it away. Trade and
consumer response has been highly favorable, and dental professionals have
reacted with exceptional enthusiasm.
The substantial growth in Braun Oral-B plaque remover sales has generated
an increasingly important market in replacement brush heads. In 1998, refill
sales rose at a rate nearly twice that of plaque removers.
Reflecting these advances, Braun again enlarged the worldwide leadership
position in oral care appliances it has held for six consecutive years.
Among household appliances, which posted somewhat lower sales, Braun
retained its number one standing in the world handblender market. Braun hair
care appliance sales recorded a sharp decline.
Although sales of personal diagnostic appliances were well below those of
1997, Braun ThermoScan infrared ear thermometers remained the top seller
worldwide. At midyear, Braun entered a new category with the launch of VitalScan
blood pressure monitors in Europe.
Supported by technological innovation, outstanding design and superior
quality throughout its product categories, Braun has a solid foundation for
sustained growth in the years to come.
[PHOTOGRAPH OF BRAUN PRODUCTS]
The Braun Oral-B 3D plaque remover PAGE 13
1
10
ORAL-B
BUSINESS SEGMENT SALES
$ Millions
----------
94 402
95 440
96 547
97 624
98 642
Building on the record results of 1997, Oral-B again last year strengthened its
position as the clear leader of the global toothbrush market. Sales moved
slightly higher, while profits climbed sharply from those of the year before.
Oral-B has long been recognized for its broad range of superior oral care
products. Chief among these are Oral-B toothbrushes, the brand used by more
dentists and consumers than any other in the United States and many major
international markets.
Worldwide sales of Oral-B toothbrushes advanced modestly in 1998,
restrained by market contraction in the Asia-Pacific region, but supported by
the performance of both new and established products.
The most recent addition to Oral-B's array of powerful brands -- the new
CrossAction premium toothbrush -- was introduced in the United States at
year-end, following three years of development. Featuring uniquely engineered
CrissCross bristles angled in opposing directions for a more effective brush
stroke, this innovative toothbrush is clinically proven to offer a new standard
in plaque removal. Trade and consumer response has been excellent. Distribution
is under way throughout the United States and will expand to key markets abroad
later in 1999.
Among established products, the best-selling Oral-B Advantage line of
toothbrushes turned in another good performance, with worldwide sales well above
those of the prior year. Substantial gains by the Contura and Prudent toothbrush
brands, both sold overseas, also contributed to Oral-B's upward sales trend.
In the children's toothbrush market, Oral-B remained the leader in the
United States on the strength of a good sales increase. This was due largely to
Oral-B's continuing partnership with the top-rated Nickelodeon cable television
network. Through this partnership, Oral-B markets popular Nickelodeon and
Rugrats toothbrushes and toothpastes. Building on the success of this approach,
Oral-B has reached similar licensing agreements involving a variety of animated
children's characters in international markets.
Interdental products posted worldwide sales well above those of the
previous year, primarily reflecting significant growth in Oral-B dental floss,
especially in Western Europe and Latin America. This spring, Oral-B is
introducing SatinFloss, a shred-resistant dental floss whose oval shape and
satin-like finish help it slide comfortably through even the tightest spaces,
thus encouraging regular flossing.
Despite considerable gains in children's toothpaste, worldwide sales of
Oral-B specialty toothpastes were somewhat lower. Mouth rinse sales moved ahead
moderately, while sales of professional products showed good progress.
Superior new products developed in partnership with dental professionals, a
broader geographic presence and momentum from its 1998 performance offer Oral-B
excellent prospects for the future.
[PHOTOGRAPH OF ORAL-B PRODUCTS]
Oral-B CrossAction toothbrushes
PAGE 14
11
ADVANTAGE
Squish
Grip
Oral-B CrossAction
[PHOTOGRAPH OF ORAL-B CROSSACTION TOOTHBRUSHES]
contura
indicator
GRiPPER
12
DURACELL
DURACELL
ULTRA
DURACELL
ULTRA
[PHOTOGRAPH OF DURACELL ULTRA BATTERIES]
DURACELL
13
DURACELL
BUSINESS SEGMENT SALES
$ Millions
----------
94 1865
95 2040
96 2251
97 2478
98 2576
Buoyed by record results in 1998, Duracell further expanded its clear global
leadership position in the rapidly growing alkaline battery business. Sales of
Duracell products registered a moderate increase, and profits were markedly
above those of the prior year.
Duracell's highly successful business development in its second year as
part of The Gillette Company reflected the refocusing of technical efforts
toward alkaline battery improvements, enlargement of its presence
internationally and continued upgrading of consumers to new and
better-performing alkaline batteries.
A disposable energy source that powers a broad range of consumer products,
alkaline batteries are Duracell's principal line of business. Worldwide sales of
alkaline batteries moved well above those of the year before, due largely to the
excellent market performance of new Duracell Ultra high-tech batteries.
Introduced last spring in North America and Western Europe in AA and AAA
sizes only, Duracell Ultra was the first alkaline battery specifically designed
to deliver long life and enhanced performance in high technology consumer
devices. A fast-growing market, these devices include cellular phones, digital
and flash cameras and camcorders.
This spring, Duracell is launching an improved Duracell Ultra battery
technology that significantly increases battery life. At the same time, Duracell
is extending the Duracell Ultra battery range, both geographically, through
introduction to a large number of international markets, and by offering the
brand's improved technology in C, D and 9-volt battery sizes.
In all, the full line of Duracell Ultra alkaline batteries will provide up
to 50 percent longer life than ordinary batteries across the spectrum of
high-tech consumer devices.
Duracell's specialty battery business consists primarily of lithium
batteries, used chiefly in cameras, and zinc air batteries, which power hearing
aids. Led by good advances in the United States and Western Europe, worldwide
sales rose moderately. During 1999, Duracell will introduce under the Duracell
Ultra brand a line of superior photo lithium batteries in four popular sizes.
In addition to its technological achievements, Duracell has strengthened
its leadership position through strategic acquisitions in important battery
markets abroad. During 1998, Duracell made two such moves. With the acquisition
of the Geep battery business, Duracell greatly expanded its presence in India,
the world's fourth largest battery market. In South Korea, Duracell gained
market leadership after acquiring the top-selling Rocket battery brand.
Innovative new products resulting from a high level of research and
development spending, together with continued geographic expansion and selective
acquisitions, should enhance Duracell's bright prospects around the world.
[PHOTOGRAPH OF DURACELL AND DURACELL ULTRA BATTERIES]
Duracell Ultra high-tech alkaline batteries
PAGE 17
14
The Gillette Company and Subsidiary Companies
MANAGEMENT'S DISCUSSION
- --------------------------------------------------------------------------------
RESULTS OF OPERATIONS
- --------------------------------------------------------------------------------
NET SALES
Net sales in 1998 were $10.1 billion, matching those of 1997. Volume/new
products and prices contributed equally to a 3% sales increase, which was offset
by unfavorable exchange rates. Excluding unfavorable exchange and the
divestiture of Jafra Cosmetics International, sales growth was 5%. In 1997,
sales growth of 4% was due to a 7% gain from volume and new products, as well as
a 1% increase from pricing, while the effect of unfavorable exchange rates
depressed sales by 4%.
Sales in the United States grew 4% in 1998, following a 3% increase in
1997. Foreign sales declined 2%, after a 4% gain in 1997. Excluding exchange,
foreign sales grew 3%. Sales in Western Europe rose 8% from the 1997 level.
Sales in Latin America were 10% below those of 1997, due to the divestiture of
Jafra in April 1998 and trade destocking in Brazil, related to higher interest
rates. Sales in other international markets were 12% below those of 1997, due to
the economic deterioration in Russia and the Asian financial crisis. Sales of
operations outside the United States represented 62% of sales in 1998 and 63% of
sales in 1997.
An analysis of sales by business segment follows.
% Increase/
(Millions of dollars) (Decrease)
-------------------------- -------------
1998 1997 1996 98/97 97/96
======= ======= ====== ===== =====
Blades & Razors.............. $ 3,028 $ 2,881 $2,836 5 2
Toiletries................... 1,214 1,410 1,375 (14) 3
Stationery Products.......... 856 924 915 (7) 1
Braun Products............... 1,740 1,744 1,773 -- (2)
Oral-B Products.............. 642 624 547 3 14
Duracell Products............ 2,576 2,478 2,251 4 10
Other........................ -- 1 1 -- --
------- ------- ------ ----- -----
$10,056 $10,062 $9,698 -- 4
======= ======= ====== ===== =====
Further information by business segment is set forth on pages 6 through 17.
Sales of blades and razors were above those of a year earlier. This
reflected gains in the United States and rapid growth in Western Europe, both
driven by the launch of the Mach3 shaving system. Results in other international
markets were lower, due to broad-based negative economic factors. Blade and
razor sales rose slightly in 1997, as considerably higher sales in developing
markets and marginally higher sales in the United States were partially offset
by sales in Western Europe that were well below those of the prior year, due to
foreign exchange.
In 1998, toiletries sales were substantially below those of the prior year,
due to the divestiture of Jafra and a significant decrease in sales of White
Rain hair care products. Sales rose modestly in 1997, reflecting the continued
expansion of the Gillette Series male grooming line, the success of Satin Care
female grooming products and the growth of clear deodorants/antiperspirants.
Sales of stationery products were well below those of 1997, due primarily
to the substantial negative impact of the Asian financial crisis. Sales in the
United States and Western Europe were virtually unchanged from those of the
prior year. In 1997, sales of stationery products were level, as decreases in
Western Europe, due to foreign exchange, offset gains in other international
markets and in the United States.
Braun product sales in 1998 showed little change from those of the prior
year, as higher sales in Western Europe and the United States countered
substantially lower sales in Asia. Sales in 1997 were marginally below those of
1996, due to adverse economic conditions and unfavorable exchange rates in Japan
and Western Europe.
Sales of Oral-B products were slightly higher than in 1997. Sales well
above those of the prior year in the United States were partially offset by
significantly lower sales in Asia. Sales grew substantially in 1997, reflecting
increased volume in the United States and the success of new products in other
major markets.
In 1998, sales of Duracell products were moderately higher, as the launch
of Duracell Ultra batteries and price increases contributed to notably higher
sales in the United States and to sales well above those of the prior year in
Western Europe. Sales rose considerably in 1997, particularly in the United
States, as well as in the AMEE and Asia-Pacific regions. Growth in the latter
two areas was aided by the full-year impact of acquisitions in South Africa and
South Korea in 1996. Excluding these acquisitions, sales in 1997 were higher
than in 1996.
- --------------------------------------------------------------------------------
GROSS PROFIT
Gross profit decreased $28 million in 1998 and increased $215 million in 1997.
As a percent of sales, gross profit was 61.7% in 1998, compared with 61.9% in
1997 and 62.0% in 1996. The slight decrease in 1998 and 1997 was due to a less
favorable product mix.
PAGE 18
15
The Gillette Company and Subsidiary Companies
MANAGEMENT'S DISCUSSION
- --------------------------------------------------------------------------------
SELLING, GENERAL AND
ADMINISTRATIVE EXPENSES
Selling, general and administrative expenses amounted to 38.6% of sales,
compared with 38.8% and 40.9% in 1997 and 1996, respectively. In absolute terms,
these expenses declined 1% in 1998 and 2% in 1997.
In 1998, $613 million was spent on advertising, including sampling, and
$1,165 million on sales promotion, for a total of $1,778 million, an increase of
5% over the 1997 spending level. Spending in 1998 included the major marketing
effort behind the launch of the Mach3 shaving system, as well as support for
other new products, such as Duracell Ultra batteries. This compares with 1997
amounts of $641 million, $1,060 million and $1,701 million, respectively. In
1996, these were $710 million, $978 million and $1,688 million, respectively.
The spending in 1998 represented 17.7% of sales, compared with 16.9% and 17.4%
in 1997 and 1996, respectively. Spending for research and development decreased
2% in 1998, compared with an increase of 4% in 1997. Other marketing and
administrative expenses declined 5% in 1998 and 4% in 1997.
- --------------------------------------------------------------------------------
PROFIT FROM OPERATIONS
After a reorganization and realignment charge of $535 million, profit from
operations in 1998 was $1.79 billion, compared with $2.32 billion in 1997 and
$1.64 billion in 1996, after merger-related costs. Profit from operations in
1998, excluding the charge, represented 23.1% of sales, compared with 23.1% in
1997 and 21.1% in 1996, before merger-related costs. The charge to operations
for reorganization and realignment in 1998 reduced net income by $347 million
and fully diluted net income per common share by $.30. Costs related to the
merger with Duracell International Inc. in 1996 reduced profit from operations
by $413 million, net income by $283 million and fully diluted net income per
common share by $.25.
Within the United States, profit from operations rose 6%, compared with an
increase of 5% in 1997. Outside the United States, it decreased 9%, compared
with a gain of 17% in 1997.
In the following table, the reorganization and realignment charge and the
merger-related costs are included in Corporate/Other.
An analysis by business segment follows.
% Increase/
(Millions of dollars) (Decrease)
1998 1997 1996 98/97 97/96
====== ====== ====== ===== =====
Blades & Razors.............. $1,153 $1,186 $1,098 (3) 8
Toiletries................... 54 124 91 (56) 36
Stationery Products.......... 108 156 122 (31) 28
Braun Products............... 291 304 300 (4) 1
Oral-B Products.............. 101 85 58 20 47
Duracell Products............ 597 526 450 13 17
------ ------ ------ ----- -----
2,304 2,381 2,119 (3) 12
------ ------ ------ ----- -----
Corporate/Other.............. (515) (57) (483)
------ ------ ------
$1,789 $2,324 $1,636
====== ====== ======
See Notes to Consolidated Financial Statements for segment and geographic area
data.
Profits for the blade and razor segment were modestly lower in 1998, due to
start-up expenses for the Mach3 shaving system. Profits moved well ahead in
1997, due to sales growth, improved product mix and lower product costs.
In 1998, toiletries reported sharply lower profits, due to the divestiture
of Jafra and significantly lower sales of White Rain hair care products. Profits
in 1997 rose substantially, as a result of sales growth, improved product mix
and lower operating expenses.
Profits for the stationery products segment were much lower in 1998, due
primarily to sales declines in the Asia-Pacific region. Profits climbed sharply
in 1997, reflecting sales growth driven by new products, improved product mix
and lower product costs.
In 1998, Braun profits were somewhat below those of the prior year, due to
lower sales of higher margin products and the Asian financial crisis. In 1997,
Braun profits were about the same as in 1996.
Oral-B profits grew significantly in both 1998 and 1997. The 1998 increase
was due to improved product mix and cost containment. The progress in 1997
reflected the success of new products with higher margins, as well as lower
operating expenses.
The Duracell segment reported a strong profit advance in 1998, due to sales
gains and the higher margin of Duracell Ultra batteries. Excellent profit growth
was achieved in 1997, led by the developing international markets.
PAGE 19
16
The Gillette Company and Subsidiary Companies
MANAGEMENT'S DISCUSSION
- --------------------------------------------------------------------------------
NONOPERATING CHARGES/INCOME
Net interest expense amounted to $86 million in 1998, $69 million in 1997 and
$67 million in 1996. Net interest expense was higher in 1998, due to increased
borrowings to fund the Company's share repurchase program, capital investments
and its pension plans in Germany. The increase in 1997 reflected higher average
borrowing levels, due to the full-year impact of 1996 acquisitions and
significant capital spending.
Net exchange losses of $23 million in 1998, which compared with 1997 and
1996 totals of $18 million and $32 million, respectively, were attributable
primarily to subsidiaries in highly inflationary countries. Translation
adjustments resulting from currency fluctuations in non-highly inflationary
countries are accumulated in a separate section of stockholders' equity, as
noted on page 29. In 1998, the negative adjustment was $36 million, compared
with negative adjustments of $268 million in 1997, reflecting significant
exchange rate movements, and $22 million in 1996.
- --------------------------------------------------------------------------------
TAXES AND NET INCOME
The effective tax rate was 35.3% in 1998, compared with rates of 35.8% in 1997
and 37.8% in 1996.
Net income for 1998 was $1,081 million, compared with $1,427 million in
1997 and $949 million in 1996. Fully diluted net income per common share in
1998 was $.95, compared with $1.24 and $.83 in 1997 and 1996, respectively.
Excluding the charge in 1998 for reorganization and realignment costs, 1998 net
income of $1,428 million matched that of 1997, and fully diluted net income per
common share of $1.25 rose 1% over the 1997 level. Excluding the charge for
merger-related costs in 1996, 1997 net income increased 16% over the $1,232
million in 1996, and fully diluted net income per common share rose 15% over the
$1.08 in 1996.
- --------------------------------------------------------------------------------
FINANCIAL CONDITION
The Company's financial condition continued to be strong in 1998. Net debt
increased $1.31 billion during 1998, reflecting significant spending under the
Company's share repurchase and capital investment programs.
Net debt (total debt net of associated swaps, less cash and cash
equivalents) at December 31, 1998, amounted to $3.18 billion, compared with
$1.87 billion and $2.08 billion at December 31, 1997 and 1996, respectively.
The market value of Gillette equity was over $52 billion at the end of
1998. The Company's book equity position amounted to $4.54 billion at the end of
1998, compared with $4.84 billion at the end of 1997 and $4.47 billion at the
end of 1996. The reduced book equity in 1998 was due to Gillette share
repurchase activity.
Net cash provided by operating activities in 1998 was $1.29 billion,
compared with $1.28 billion in 1997 and $1.01 billion in 1996. The current ratio
of the Company was 1.56 for 1998, compared with ratios of 1.78 for 1997 and 1.62
for 1996. The decrease in the 1998 current ratio was primarily attributable to
the Company's increased short-term debt at December 31, 1998.
Capital spending in 1998 amounted to a record $1.0 billion, compared with
$973 million in 1997 and $830 million in 1996. Spending in all three years
reflected significant investments in the blade and razor, Duracell and Braun
product segments.
In 1998, the Company made acquisitions in the battery segment for $100
million, while 1997 acquisition activity of $3 million was in oral care. In
1996, the Company made acquisitions, principally in the battery business, for
$361 million.
In 1998, the Jafra business was sold for $200 million.
Share repurchase funding in 1998, net of proceeds received from the sale of
put options on Company stock, amounted to $1.01 billion, compared with $26
million in 1997 and $11 million in 1996.
Enhancing its financial flexibility, the Company replaced its $1.0 billion
revolving credit agreement with a new $2.0 billion revolving credit facility,
expiring in October 1999. The Company also has a $1.1 billion revolving credit
agreement, which expires in December 2001. Both facilities are used by the
Company to provide back-up to its commercial paper program.
At year-end 1998, there was $1.66 billion outstanding under the Company's
commercial paper program, compared with $780 million at the end of 1997 and
$1.09 billion at the end of 1996.
During 1998, the Company issued $200 million, 5.75% Notes due August 2001
and $300 million, 5.00% Notes due December 2006. In early 1999, the Company
issued Euro 300 million, 3.25% Notes due February 2004. The net proceeds were
used to refinance existing short-term debt and for other general corporate
purposes.
During 1998, both Standard & Poor's and Moody's maintained the Company's
current credit ratings. Stan-
PAGE 20
17
The Gillette Company and Subsidiary Companies
MANAGEMENT'S DISCUSSION
dard & Poor's rates the Company's long-term debt at AA, while Moody's rating is
Aa3. The commercial paper rating is A1+ by Standard & Poor's and P1 by Moody's.
Gillette will continue to have capital available for growth through both
internally generated funds and substantial credit resources. The Company has
substantial unused lines of credit and access to worldwide financial market
sources for funds.
- --------------------------------------------------------------------------------
MARKET RISK
The Company uses financial instruments such as derivatives to hedge its exposure
to market risk arising from changes in interest rates and foreign currency
exchange rates. Gillette has established clear policies, procedures and internal
accounting and administrative controls governing the use of financial
instruments to manage its exposure to such risks. The Company does not purchase,
sell or hold any derivative financial instruments for trading, profit or
speculative purposes.
Gillette uses product sourcing and pricing as a natural hedge to its
foreign currency revenues and costs, thus limiting the Company's profit exposure
to foreign currency fluctuations. In addition, when considered appropriate, the
Company purchases foreign currency options with periods consistent with the
related underlying exposures.
Gillette enters into currency forwards, swaps and interest rate swaps in
order to effectively mitigate financial risk. The swaps are entered into with
notional amounts, interest rates and time periods that match the underlying
debt.
The Company uses swaps and options to hedge equity-linked compensation
liability exposures with terms that match the underlying exposures. The Company
sells equity put options to supplement open market purchases of its common
stock.
Financial instrument positions are monitored using value-at-risk
techniques. Value at risk is estimated for each instrument based on historical
volatility of market rates and a 95% confidence level.
Based on the Company's overall evaluation of its market risk exposures from
all of its financial instruments at December 31, 1998 and 1997, a near-term
change in market rates would not materially affect the consolidated financial
position, results of operations or cash flows of the Company.
- --------------------------------------------------------------------------------
REORGANIZATION AND REALIGNMENT
On September 28, 1998, the Company announced a reorganization and realignment
program that resulted in a third-quarter charge to operations of $535 million
($347 million after taxes, or $.30 in net income per common share, fully
diluted).
The worldwide reorganization of operations will aid the Company in several
ways. It will strengthen the global business management focus on the six core
product categories, enhance the global focus on new product development and
manufacturing, achieve more effective leveraging of global resources, respond to
changing worldwide business conditions and improve the Company's ability to
rapidly expand product offerings to consumers through worldwide trade channels.
The program will result in a reduction of approximately 4,700 employees
across all business segments, geographies and employee groups. Pretax cash
outlays were $16 million in 1998 and are estimated at approximately $180 million
in 1999 and $160 million in 2000. Cash severance payments will extend beyond the
completion of program activities, due to the severance payment options available
to affected employees. In 1999, cash expenditures from the program are expected
to be greater than the cash benefits generated. Cash requirements will be funded
from operations. When fully implemented in 2000, the program will generate
pretax savings of approximately $200 million annually.
After a year-long review, the Company identified manufacturing
rationalization opportunities for 14 factories and 12 warehouses. During this
review, it was determined that some factories have underutilized capacity,
others are technologically obsolete and, due to the Company's recent redesign of
portions of the worldwide supply chain, others are no longer required.
The customer management function -- selling, merchandising and product
promotion -- will undergo a global rationalization that will consolidate these
activities into core product teams.
The Commercial Operations groups will be serviced by common administrative
support functions located in each geography. These shared service centers will
enable the closure of 30 office facilities.
The assets affected by this program include factories, warehouses and
office facilities, as well as manufacturing, distribution and office equipment.
The carrying amount of the assets held for disposal is $39 million. Asset
disposals began at the end of 1998
PAGE 21
18
The Gillette Company and Subsidiary Companies
MANAGEMENT'S DISCUSSION
and will be substantially completed within 18 months. Nearly all of the
revenue-generating activities related to the assets held for disposal will
continue as a result of more effective utilization of other assets. Although all
assets held for disposal may be removed from use at any time, they will be
removed in stages to allow for an orderly implementation of all actions.
Buildings that are owned will be sold, and equipment will be disposed of through
sale or abandonment.
The fair value of the impaired assets was determined based on past
experience with the disposal of comparable assets and third-party appraisals.
The closure of two manufacturing facilities in late 1998 contributed to
fourth-quarter savings of $4 million. Employee reductions through December 31,
1998, totaled 620 employees. Progress to date has met expectations, and the pace
of realignment activities is accelerating. In 1999, approximately 40% of the
annual benefit should be achieved, with the majority of the estimated annual
savings realized in 2000, when the program is completed.
Additional details are provided in the Notes to Consolidated Financial
Statements.
- --------------------------------------------------------------------------------
YEAR 2000
The Company is undertaking a comprehensive approach to address its potential
exposure to the Year 2000 issue -- covering all potentially affected areas
(applications, computers, facilities, manufacturing equipment, suppliers,
customers, etc.) at all locations. Efforts to address the Year 2000 issue began
in 1995 at major sites, and a formal Program Management Office was established
in 1997. This office has focused on setting program policy, tracking progress,
identifying best practices and leveraging common solutions.
The Year 2000 Program Management Office developed a structured, six-phase
program that is being consistently implemented at all locations worldwide. The
first phase is discovery. This phase includes identifying all potentially
affected items, including information technology and noninformation technology
items, assessing compliance and defining the potential business impact of each
noncompliant item.
The second phase is planning. A specific resolution strategy is designed
for each noncompliant item. Non-compliant items are prioritized by their
importance to the overall operations of the business. Once the items are
prioritized, the planning phase includes identifying the tasks and resources
necessary to remedy noncompliance, as well as determining when the work will be
finished.
The third phase is resolution, where the actual corrective work is done. In
addition to work within the Company, Year 2000 readiness of all significant
external business relationships is assessed in this phase.
The fourth phase is testing, validating that the corrective work activities
have been completed. The fifth phase is implementation, where the corrected
items are placed back in operation. The sixth and final phase is certification
that the corrective work has been successful.
At December 31, 1998, 90% of the affected items identified were at the
sixth phase, i.e., certified to be Year 2000 compliant, or their risks have been
minimized to an appropriate level. The Company expects to make substantial
progress on the remaining items by June 30, 1999. The remaining tasks have been
identified and are well understood. Resources have been assigned, and the work
is under way.
The Company also has an extensive quality assurance program in place,
designed to ensure that Year 2000 activities are accomplishing their objectives.
Several multiyear initiatives have been in progress to support the changing
business and, secondarily, to address the Year 2000 issue, such as
implementation of SAP, PeopleSoft and JDE software applications.
The Company continues to develop detailed contingency plans to deal with
unexpected issues, which may occur. These plans include the identification of
appropriate resources and response teams.
Despite this comprehensive approach, the Company cannot be completely sure
that issues will not arise, nor events occur, that could have material adverse
effects on the Company's results of operations or financial condition.
Nevertheless, Gillette does not expect a material failure. The Company's Year
2000 program is designed to minimize the likelihood of any failure occurring.
The most reasonably likely worst-case scenario is that a short-term disruption
will occur with a small number of customers or suppliers, requiring an
appropriate response. In addition, Gillette operations depend on infrastructures
within all countries in which the Company operates and, therefore, a failure of
any one of those infrastructures could materially adversely affect its
operations.
Spending for the program is budgeted, expensed as incurred and not expected
to be material.
PAGE 22
19
The Gillette Company and Subsidiary Companies
MANAGEMENT'S DISCUSSION
- --------------------------------------------------------------------------------
EURO CONVERSION
The Company has a Euro project team responsible for ensuring the Company's
ability to operate effectively during the Euro transition phase and through
final Euro conversion. Total costs for the entire Euro conversion program are
not expected to be material.
Conversion to the Euro may affect competition between markets, due to price
transparency. Gillette is carefully monitoring its marketing and pricing
strategies throughout the more open European market. The Company also is
converting finance and information technology systems to make and receive
payments in Euros in early 1999 and to use the Euro as its base currency in
relevant markets from January 1, 2001, onward. Existing contracts are being
reviewed for any required modifications. Based on the analysis and actions taken
to date, the Company does not expect the Euro conversion to materially affect
the consolidated financial position, results of operations or cash flows of the
Company.
- --------------------------------------------------------------------------------
FORWARD-LOOKING STATEMENTS
AND CAUTIONARY STATEMENT
This report contains "forward-looking statements" about the Company's prospects
and progress. Investors should be aware of factors that could have a negative
impact on prospects and the consistency of progress. These include political,
economic or other factors such as currency exchange rates, inflation rates,
recessionary or expansive trends, taxes and regulations and laws affecting the
worldwide business in each of the Company's markets; competitive product,
advertising, promotional and pricing activity; dependence on the rate of
development and degree of acceptance of new product introductions in the
marketplace; and the difficulty of forecasting sales at certain times in certain
markets. Any such "forward-looking statements" also are qualified by the
detailed statement under Item 7, Cautionary Statement, in the Company's most
recent Annual Report on Form 10-K, and under Item 5, Cautionary Statement, in
the Company's most recent Quarterly Report on Form 10-Q.
- --------------------------------------------------------------------------------
RESPONSIBILITY FOR
FINANCIAL STATEMENTS
The Company is responsible for the objectivity and integrity of the accompanying
consolidated financial statements, which have been prepared in conformity with
generally accepted accounting principles. The financial statements of necessity
include the Company's estimates and judgments relating to matters not concluded
by year-end. Financial information contained elsewhere in the Annual Report is
consistent with that included in the financial statements.
The Company maintains a system of internal accounting controls that
includes careful selection and development of employees, division of duties, and
written accounting and operating policies and procedures augmented by a
continuing internal audit program. Although there are inherent limitations to
the effectiveness of any system of accounting controls, the Company believes
that its system provides reasonable, but not absolute, assurance that its assets
are safeguarded from unauthorized use or disposition and that its accounting
records are sufficiently reliable to permit the preparation of financial
statements that conform in all material respects with generally accepted
accounting principles.
KPMG Peat Marwick LLP, independent auditors, are engaged to render an
independent opinion regarding the fair presentation in the financial statements
of the Company's financial condition and operating results. Their report appears
on page 39. Their examination was made in accordance with generally accepted
auditing standards and included a review of the system of internal accounting
controls to the extent they considered necessary to determine the audit
procedures required to support their opinion.
The Audit Committee of the Board of Directors is composed solely of
directors who are not employees of the Company. The Committee meets periodically
and privately with the independent auditors, with the internal auditors and with
the financial officers of the Company to review matters relating to the quality
of the financial reporting of the Company, the internal accounting controls and
the scope and results of audit examinations. The Committee also reviews
compliance with the Company's statement of policy as to the conduct of its
business, including proper accounting, financial reporting and management of the
relationship with the auditors. In addition, it is responsible for recommending
the appointment of the Company's independent auditors, subject to stockholder
approval.
PAGE 23
20
The Gillette Company and Subsidiary Companies
CONSOLIDATED STATEMENT
OF INCOME
(Millions of dollars, except per share amounts)
Years Ended December 31, 1998, 1997 and 1996 1998 1997 1996
=============================================================== ======= ======= ======
NET SALES ..................................................... $10,056 $10,062 $9,698
Cost of Sales ................................................. 3,853 3,831 3,682
------- ------- ------
GROSS PROFIT .................................................. 6,203 6,231 6,016
Selling, General and Administrative Expenses .................. 3,879 3,907 3,967
Reorganization and Realignment Expenses ....................... 535 -- --
Merger-Related Costs .......................................... -- -- 413
------- ------- ------
PROFIT FROM OPERATIONS ........................................ 1,789 2,324 1,636
Nonoperating Charges (Income)
Interest income .............................................. (8) (9) (10)
Interest expense ............................................. 94 78 77
Other charges - net .......................................... 34 34 44
------- ------- ------
120 103 111
------- ------- ------
INCOME BEFORE INCOME TAXES .................................... 1,669 2,221 1,525
Income Taxes .................................................. 588 794 576
------- ------- ------
NET INCOME .................................................... $ 1,081 $ 1,427 $ 949
======= ======= ======
NET INCOME PER COMMON SHARE, BASIC ............................ $ .96 $ 1.27 $ .85
NET INCOME PER COMMON SHARE, ASSUMING FULL DILUTION ........... $ .95 $ 1.24 $ .83
Weighted average number of common shares outstanding (millions)
Basic ........................................................ 1,117 1,118 1,107
Assuming full dilution ....................................... 1,144 1,148 1,140
=============================================================== ======= ======= ======
See accompanying Notes to Consolidated Financial Statements.
PAGE 24
21
The Gillette Company and Subsidiary Companies
CONSOLIDATED BALANCE SHEET
(Millions of dollars)
December 31, 1998 and 1997 1998 1997
============================================================================ ======= =======
ASSETS
CURRENT ASSETS
Cash and cash equivalents ................................................. $ 102 $ 105
Receivables, less allowances: 1998 - $79; 1997 - $74 ...................... 2,943 2,522
Inventories ............................................................... 1,595 1,500
Deferred income taxes ..................................................... 517 320
Other current assets ...................................................... 283 243
------- -------
TOTAL CURRENT ASSETS ..................................................... 5,440 4,690
------- -------
PROPERTY, PLANT AND EQUIPMENT, at cost less accumulated depreciation ....... 3,472 3,104
INTANGIBLE ASSETS, less accumulated amortization ........................... 2,448 2,423
OTHER ASSETS ............................................................... 542 647
------- -------
$11,902 $10,864
======= =======
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Loans payable ............................................................. $ 981 $ 552
Current portion of long-term debt ......................................... 9 9
Accounts payable and accrued liabilities .................................. 2,170 1,794
Income taxes .............................................................. 318 286
------- -------
TOTAL CURRENT LIABILITIES ................................................ 3,478 2,641
------- -------
LONG-TERM DEBT ............................................................. 2,256 1,476
DEFERRED INCOME TAXES ...................................................... 411 359
OTHER LONG-TERM LIABILITIES ................................................ 898 1,101
MINORITY INTEREST .......................................................... 39 39
CONTINGENT REDEMPTION VALUE OF COMMON STOCK PUT OPTIONS .................... 277 407
STOCKHOLDERS' EQUITY
8.0% Cumulative Series C ESOP Convertible Preferred, without par value,
Issued: 1998 - 148,627 shares; 1997 - 154,156 shares ..................... 90 93
Unearned ESOP compensation ................................................ (10) (17)
Common stock, par value $1 per share
Authorized: 2,320,000,000 shares
Issued: 1998 - 1,357,913,938 shares; 1997 - 1,352,581,842 shares ......... 1,358 1,353
Additional paid-in capital ................................................ 621 309
Earnings reinvested in the business ....................................... 5,529 5,021
Accumulated other comprehensive income
Foreign currency translation ............................................. (826) (790)
Pension adjustment ....................................................... (47) (20)
Treasury stock, at cost:
1998 - 252,507,187 shares; 1997 - 231,643,130 shares ..................... (2,172) (1,108)
------- -------
TOTAL STOCKHOLDERS' EQUITY ............................................... 4,543 4,841
------- -------
$11,902 $10,864
======= =======
=================================================================================================
See accompanying Notes to Consolidated Financial Statements.
PAGE 25
22
The Gillette Company and Subsidiary Companies
CONSOLIDATED STATEMENT
OF CASH FLOWS
(Millions of dollars)
Years Ended December 31, 1998, 1997 and 1996 1998 1997 1996
================================================================================== ====== ====== ======
OPERATING ACTIVITIES
Net income ...................................................................... $1,081 $1,427 $ 949
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for reorganization and realignment ................................... 535 -- --
Merger-related costs ........................................................... -- -- 413
Depreciation and amortization .................................................. 459 422 381
Other .......................................................................... (46) (23) --
Changes in assets and liabilities, net of effects from acquisition of businesses:
Accounts receivable ........................................................... (435) (340) (459)
Inventories ................................................................... (123) (157) (105)
Accounts payable and accrued liabilities ...................................... 72 29 67
Other working capital items ................................................... (121) 80 (227)
Other noncurrent assets and liabilities ....................................... (133) (158) (11)
------ ------ ------
Net cash provided by operating activities .................................... 1,289 1,280 1,008
------ ------ ------
INVESTING ACTIVITIES
Additions to property, plant and equipment ...................................... (1,000) (973) (830)
Disposals of property, plant and equipment ...................................... 88 59 41
Acquisition of businesses, less cash acquired ................................... (91) (3) (299)
Sale of business ................................................................ 200 -- --
Other ........................................................................... 5 12 (1)
------ ------ ------
Net cash used in investing activities ........................................ (798) (905) (1,089)
------ ------ ------
FINANCING ACTIVITIES
Purchase of treasury stock ...................................................... (1,066) (53) (11)
Proceeds from sale of put options ............................................... 56 27 --
Proceeds from exercise of stock option and purchase plans ....................... 126 210 150
Funding German pension plans..................................................... (252) -- --
Proceeds from long-term debt .................................................... 500 300 --
Decrease in long-term debt ...................................................... (12) (6) (165)
Increase (decrease) in loans payable ............................................ 708 (383) 578
Dividends paid .................................................................. (552) (466) (451)
------ ------ ------
Net cash provided by (used in) financing activities .......................... (492) (371) 101
------ ------ ------
EFFECT OF EXCHANGE RATE CHANGES ON CASH .......................................... (2) (7) (19)
NET CASH FROM HARMONIZATION PERIOD ............................................... -- 24 --
------ ------ ------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS ................................. (3) 21 1
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR ................................... 105 84 83
------ ------ ------
CASH AND CASH EQUIVALENTS AT END OF YEAR ......................................... $ 102 $ 105 $ 84
====== ====== ======
Supplemental disclosure of cash paid for:
Interest ....................................................................... $ 120 $ 101 $ 94
Income taxes ................................................................... $ 478 $ 451 $ 586
Noncash investing and financing activities:
Acquisition of businesses
Fair value of assets acquired ................................................. $ 100 $ 3 $ 361
Cash paid ..................................................................... 91 3 300
------ ------ ------
Liabilities assumed .......................................................... $ 9 $ -- $ 61
====== ====== ======
See accompanying Notes to Consolidated Financial Statements.
PAGE 26
23
The Gillette Company and Subsidiary Companies
CONSOLIDATED STATEMENT OF
STOCKHOLDERS' EQUITY
Unearned Additional
Preferred ESOP Common Paid-in
(Millions of dollars) Shares Compensation Stock Capital
========================================= ========= ============ ====== ==========
Balance at December 31, 1995 ............ $ 97 $ (34) $1,334 $345
---- ----- ------ ----
Net income ............................. -- -- -- --
Cumulative translation adjustments -- -- -- --
Minimum liability adjustment .......... -- -- -- --
Other comprehensive income ........... -- -- -- --
Comprehensive income ................
Dividends declared ..................... -- -- -- --
Stock option and purchase plans
(8,725,960 shares) .................... -- -- 9 141
Conversion of Series C ESOP
preferred stock (222,132 shares) ...... (2) -- -- 1
Purchase of Gillette treasury stock
(420,800 shares) ...................... -- -- -- --
Earned ESOP compensation ............... -- 9 -- --
---- ----- ------ ----
Balance at December 31, 1996 ............ 95 (25) 1,343 487
---- ----- ------ ----
Net income ............................. -- -- -- --
Net results of year-end harmonization -- -- -- --
Cumulative translation adjustments -- -- -- --
Other comprehensive income ........... -- -- -- --
Comprehensive income ................
Dividends declared ..................... -- -- -- --
Stock option and purchase plans
(9,718,242 shares) .................... -- -- 10 201
Conversion of Series C ESOP
preferred stock (301,444 shares) ...... (2) -- -- 1
Purchase of Gillette treasury stock
(1,237,200 shares) .................... -- -- -- --
Proceeds from sale of put options ...... -- -- -- 27
Contingent liability of put options .... -- -- -- (407)
Earned ESOP compensation ............... -- 8 -- --
---- ----- ------ ----
Balance at December 31, 1997 ............ 93 (17) 1,353 309
---- ----- ------ ----
Net income ............................. -- -- -- --
Cumulative translation adjustments -- -- -- --
Minimum liability adjustment .......... -- -- -- --
Other comprehensive income ........... -- -- -- --
Comprehensive income ................
Dividends declared ..................... -- -- -- --
Stock option and purchase plans
(5,332,096 shares) .................... -- -- 5 125
Conversion of Series C ESOP
preferred stock (442,343 shares) ...... (3) -- -- 1
Purchase of Gillette treasury stock
(21,306,400 shares) ................... -- -- -- --
Proceeds from sale of put options ...... -- -- -- 56
Contingent liability of put options .... -- -- -- 130
Earned ESOP compensation ............... -- 7 -- --
---- ----- ------ ----
Balance at December 31, 1998 ............ $ 90 $ (10) $1,358 $621
==== ===== ====== ====
Other Total
Earnings Treasury Comprehensive Stockholders'
(Millions of dollars) Reinvested Stock Income Equity
========================================= ========== ======== ============= =============
Balance at December 31, 1995 ............ $3,704 $(1,046) $(521) $3,879
------ ------- ----- ------
Net income ............................. 949 -- -- 949
Cumulative translation adjustments -- -- (22) (22)
Minimum liability adjustment .......... -- -- 1 1
----- ------
Other comprehensive income ........... -- -- (21) (21)
----- ------
Comprehensive income ................ 928
------
Dividends declared ..................... (484) -- -- (484)
Stock option and purchase plans
(8,725,960 shares) .................... -- -- -- 150
Conversion of Series C ESOP
preferred stock (222,132 shares) ...... -- 1 -- --
Purchase of Gillette treasury stock
(420,800 shares) ...................... -- (11) -- (11)
Earned ESOP compensation ............... -- -- -- 9
------ ------- ----- ------
Balance at December 31, 1996 ............ 4,169 (1,056) (542) 4,471
------ ------- ----- ------
Net income ............................. 1,427 -- -- 1,427
Net results of year-end harmonization (89) -- -- (89)
Cumulative translation adjustments -- -- (268) (268)
----- ------
Other comprehensive income ........... -- -- (268) (268)
----- ------
Comprehensive income ................ 1,070
------
Dividends declared ..................... (486) -- -- (486)
Stock option and purchase plans
(9,718,242 shares) .................... -- -- -- 211
Conversion of Series C ESOP
preferred stock (301,444 shares) ...... -- 1 -- --
Purchase of Gillette treasury stock
(1,237,200 shares) .................... -- (53) -- (53)
Proceeds from sale of put options ...... -- -- -- 27
Contingent liability of put options .... -- -- -- (407)
Earned ESOP compensation ............... -- -- -- 8
------ ------- ----- ------
Balance at December 31, 1997 ............ 5,021 (1,108) (810) 4,841
------ ------- ----- ------
Net income ............................. 1,081 -- -- 1,081
Cumulative translation adjustments -- -- (36) (36)
Minimum liability adjustment .......... -- -- (27) (27)
----- ------
Other comprehensive income ........... -- -- (63) (63)
----- ------
Comprehensive income ................ 1,018
------
Dividends declared ..................... (573) -- -- (573)
Stock option and purchase plans
(5,332,096 shares) .................... -- -- -- 130
Conversion of Series C ESOP
preferred stock (442,343 shares) ...... -- 2 -- --
Purchase of Gillette treasury stock
(21,306,400 shares) ................... -- (1,066) -- (1,066)
Proceeds from sale of put options ...... -- -- -- 56
Contingent liability of put options .... -- -- -- 130
Earned ESOP compensation ............... -- -- -- 7
------ ------- ----- ------
Balance at December 31, 1998 ............ $5,529 $(2,172) $(873) $4,543
====== ======= ===== ======
Dividends declared per common share in 1998, 1997 and 1996 were $.51, $.43 and
$.36, respectively, for Gillette, and in 1996, $.58 for Duracell.
================================================================================
See accompanying Notes to Consolidated Financial Statements.
PAGE 27
24
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
- --------------------------------------------------------------------------------
NATURE OF OPERATIONS
The Gillette Company is a global consumer products firm, with manufacturing
operations conducted at 62 facilities in 25 countries. Products are distributed
through wholesalers, retailers and agents in over 200 countries and territories.
Gillette is the world leader in male grooming, a category that includes blades,
razors and shaving preparations, and also in female grooming products, such as
wet shaving products and hair epilation devices. The Company is the world's top
seller of writing instruments and correction products and is the world leader in
toothbrushes, oral care appliances and alkaline batteries.
- --------------------------------------------------------------------------------
BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION
The preparation of consolidated financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses. Actual results
could differ from those estimates.
The consolidated financial statements include the accounts of the Company
and its subsidiaries. Intercompany accounts and transactions are eliminated.
At the end of 1997, the year-ends of all operating groups were harmonized,
with a common calendar year-end of December 31. The results of the accounting
period necessary for harmonization -- in the aggregate a loss of $24 million --
are reflected as a charge in the stockholders' equity section of the balance
sheet. Also reflected in this section is a charge of $51 million, adjusting for
seasonality of advertising.
In the first quarter of 1997, Duracell entities outside North America
changed their year-end reporting periods to coincide with those of Gillette
operations, resulting in a charge of $14 million to stockholders' equity.
- --------------------------------------------------------------------------------
CASH AND CASH EQUIVALENTS
Cash and cash equivalents include cash, time deposits and all highly liquid debt
instruments with an original maturity of three months or less.
- --------------------------------------------------------------------------------
INVENTORIES
Inventories are stated at the lower of cost or market. In general, cost is
currently adjusted standard cost, which approximates actual cost on a first-in,
first-out basis.
- --------------------------------------------------------------------------------
DEPRECIATION
Depreciation is computed primarily on a straight-line basis over the estimated
useful lives of assets.
- --------------------------------------------------------------------------------
ADVERTISING
Advertising costs are expensed in the year incurred.
- --------------------------------------------------------------------------------
INTANGIBLE ASSETS
Intangible assets, principally goodwill, are amortized on the straight-line
method, generally over a period of 40 years. The carrying amounts of intangible
assets are assessed for impairment when operating profit from the related
business indicates that the carrying amounts of the assets may not be
recoverable.
- --------------------------------------------------------------------------------
NET INCOME PER COMMON SHARE
Basic net income per common share is calculated by dividing net income less
dividends on preferred stock, net of tax benefits, by the weighted average
number of common shares outstanding.
The calculation of fully diluted net income per common share assumes
conversion of preferred stock and stock options into common stock, and also
adjusts net income for the effect of converting the preferred stock to common
stock.
Net income and shares used to compute net income per share, basic and
assuming full dilution, are reconciled below.
(Millions) 1998 1997 1996
========================================== ====== ====== =====
Net income as reported.................... $1,081 $1,427 $ 949
Less: Preferred stock dividends........... 4 4 5
------ ------ -----
Net income, basic......................... $1,077 $1,423 $ 944
------ ------ -----
Effect of dilutive securities:
Convertible preferred stock.............. 5 4 4
------ ------ -----
Net income, assuming full dilution $1,082 $1,427 $ 948
====== ====== =====
Common shares, basic...................... 1,117 1,118 1,107
Effect of dilutive securities:
Convertible preferred stock.............. 12 12 13
Stock options............................ 15 18 20
------ ------ -----
Common shares, assuming full
dilution................................. 1,144 1,148 1,140
====== ====== =====
PAGE 28
25
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
INCOME TAXES
The Company reinvests unremitted earnings of foreign operations and,
accordingly, does not provide for Federal income taxes that could result from
the remittance of such earnings. These unremitted earnings amounted to $3.7
billion at December 31, 1998.
- --------------------------------------------------------------------------------
RECLASSIFICATION OF PRIOR YEARS
Prior year financial statements have been reclassified to conform to the 1998
presentations.
- --------------------------------------------------------------------------------
EFFECT OF ACCOUNTING CHANGES
In 1998, the Financial Accounting Standards Board issued SFAS 132, "Employers'
Disclosure about Pensions and Other Postretirement Benefits," and SFAS 133,
"Accounting for Derivative Instruments and Hedging Activities." SFAS 132 has
been adopted. SFAS 133 will be adopted no later than January 1, 2000. Its impact
on the consolidated financial statements is still being evaluated, but is not
expected to be material.
Also in 1998, the American Institute of Certified Public Accountants
issued SOP 98-1, "Accounting for the Costs of Computer Software Developed or
Obtained for Internal Use," and SOP 98-5, "Reporting on the Costs of Start-Up
Activities." The Company adopted SOP 98-1 on January 1, 1998, with no material
effect on the consolidated financial statements. The Company will adopt SOP
98-5 in 1999. It will not materially affect the consolidated financial
statements.
- --------------------------------------------------------------------------------
FOREIGN CURRENCY TRANSLATION
Net exchange gains or losses resulting from the translation of assets and
liabilities of foreign subsidiaries, except those in highly inflationary
economies, are accumulated in a separate section of stockholders' equity. Also
included are the effects of exchange rate changes on intercompany transactions
of a long-term investment nature and transactions designated as hedges of net
foreign investments.
An analysis of cumulative translation adjustments follows.
(Millions of dollars) 1998 1997 1996
======================================= ===== ===== =====
Balance at beginning of year........... $(790) $(522) $(500)
Translation adjustments, including
the effect of hedging................. (86) (222) 18
Related income tax effect.............. 50 (46) (40)
----- ----- -----
Balance at end of year................. $(826) $(790) $(522)
===== ===== =====
Included in Other charges in the Consolidated Statement of Income are net
exchange losses of $23 million, $18 million and $32 million for 1998, 1997 and
1996, respectively.
- --------------------------------------------------------------------------------
INVENTORIES
December 31, December 31,
(Millions of dollars) 1998 1997
==================================== ============ ============
Raw materials and supplies.......... $ 244 $ 279
Work in process..................... 232 186
Finished goods...................... 1,119 1,035
------ ------
$1,595 $1,500
====== ======
- --------------------------------------------------------------------------------
PROPERTY, PLANT AND
EQUIPMENT
- ----------------------------------------------------------
Land..................................... $ 69 $ 80
Buildings................................ 745 734
Machinery and equipment.................. 4,891 4,377
------ ------
5,705 5,191
Less accumulated depreciation............ 2,233 2,087
------ ------
$3,472 $3,104
====== ======
- --------------------------------------------------------------------------------
INTANGIBLE ASSETS
- ------------------------------------------------------------
Goodwill ($44 million not
subject to amortization)................ $2,068 $2,023
Other intangible assets.................. 1,194 1,128
------ ------
3,262 3,151
Less accumulated amortization............ 814 728
------ ------
$2,448 $2,423
====== ======
- --------------------------------------------------------------------------------
ACCOUNTS PAYABLE AND
ACCRUED LIABILITIES
- ------------------------------------------------------------
Accounts payable......................... $ 606 $ 542
Advertising and sales promotion.......... 391 360
Payroll and payroll taxes................ 175 221
Other taxes.............................. 85 25
Dividends payable on common stock 141 120
Reorganization/realignment expense 308 --
Merger-related costs..................... -- 101
Miscellaneous............................ 464 425
------ ------
$2,170 $1,794
====== ======
PAGE 29
26
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
OTHER LONG-TERM LIABILITIES
December 31, December 31,
(Millions of dollars) 1998 1997
======================================== ============ ============
Pensions................................ $242 $ 450
Postretirement medical.................. 305 302
Incentive plans......................... 183 171
Reorganization/realignment expense...... 38 --
Miscellaneous........................... 130 178
---- ------
$898 $1,101
==== ======
- --------------------------------------------------------------------------------
DEBT
Commercial paper included in Loans payable was $557 million at December 31,
1998, and nil at December 31, 1997. The Company's commercial paper program is
supported by its revolving credit facilities.
A summary of long-term debt follows.
December 31, December 31,
(Millions of dollars) 1998 1997
========================================= ============== =============
Commercial paper......................... $1,100 $ 780
5.00% Notes due 2006..................... 300 --
5.75% Notes due 2005..................... 200 200
6.25% Notes due 2003..................... 150 150
5.75% Notes due 2001..................... 200 --
6.00% Notes due 2000..................... 300 300
8.03% Guaranteed ESOP notes
due through 2000........................ 13 22
Other, multicurrency borrowings.......... 2 33
------ ------
Total long-term debt..................... 2,265 1,485
Less current portion..................... 9 9
------ ------
Long-term portion........................ $2,256 $1,476
====== ======
At December 31, 1998, the Company had swap agreements that converted $1.15
billion U.S. dollar-denominated long-term fixed rate debt notes into Deutschmark
and U.S. dollar principal and floating interest rate obligations, over the terms
of the respective issues, resulting in an aggregate principal amount of $1.13
billion, at a weighted average interest rate of 4.7%. As of December 31, 1997,
the Company's swap agreements converted $650 million in U.S. dollar-denominated
long-term fixed rate debt notes into Deutschmark and U.S. dollar principal and
floating interest rate obligations with an aggregate principal amount of $604
million, at a weighted average interest rate of 4.8%.
The Company also had forward exchange contracts at December 31, 1998,
maturing in 1999 and 2000, that established $818 million in multicurrency
principal, 2.7% interest obligations, with respect to $731 million of U.S.
dollar commercial paper debt included in Long-Term Debt and $32 million of
foreign currency debt included in Loans payable. At December 31, 1997, the
Company's forward exchange contracts established $373 million in multicurrency
principal, 4.2% interest obligations, with respect to $356 million of U.S.
dollar commercial paper debt included in Long-Term Debt and $33 million of
foreign currency debt included in Loans payable.
Exchange rate movements give rise to changes in the values of the foreign
currency-related agreements that offset changes in the values of the underlying
exposures. Amounts associated with these agreements were payables of $33 million
at December 31, 1998, and receivables of $62 million at December 31, 1997.
The weighted average interest rate on Loans payable, including associated
swaps, was 4.8% at December 31, 1998, and 4.2% at December 31, 1997. The
weighted average interest rate on total long-term debt, including associated
swaps and excluding the guaranteed ESOP notes, was 4.1% and 5.3% at December 31,
1998 and 1997, respectively.
The Company has a $2.0 billion revolving bank credit agreement that expires
in October 1999 and a $1.1 billion revolving bank credit agreement expiring in
December 2001, both of which may be used for general corporate purposes. Under
the agreements, the Company has the option to borrow at various interest rates,
including the prime rate, and is required to pay an average facility fee of
.039% per annum. At year-end 1998 and 1997, there were no borrowings under such
agreements.
Based on the Company's intention and ability to maintain its $1.1 billion
revolving credit agreement beyond 1999, $1.1 billion of commercial paper
borrowing was classified as long-term debt at December 31, 1998. As of December
31, 1997, $780 million of commercial paper borrowings and $20 million of Loans
payable were so classified.
Aggregate maturities of total long-term debt for the five years subsequent
to December 31, 1998, are $9 million in 1999, $305 million in 2000, $200 million
in 2001 and $150 million in 2003.
Unused lines of credit, including the revolving bank credit agreements,
amounted to $3.8 billion at December 31, 1998.
PAGE 30
27
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
FINANCIAL INSTRUMENTS
The Company uses financial instruments, principally swaps, forward contracts and
options, to achieve its financing strategy and to hedge foreign currency,
commodity and equity-linked employee compensation exposures. These contracts
hedge transactions and balances for periods consistent with their committed
exposures and do not constitute investments independent of these exposures. The
Company does not hold or issue financial instruments for trading purposes, nor
is it a party to any leveraged contracts.
Realized and unrealized foreign exchange gains and losses on financial
instruments are recognized and offset foreign exchange gains and losses on the
underlying exposures. Any gain or loss from a financial instrument that ceases
to be an effective hedge is recognized in the income statement. The interest
differential paid or received on swap and forward agreements is recognized as an
adjustment to interest expense.
During 1998, the Company purchased foreign currency put options, with a
strike price of $159 million and a cost of $12 million, to protect 1998 U.S.
dollar results. The options expired $14 million in the money and all related
gains and expenses were included within 1998 profit from operations. At December
31, 1998, the Company had purchased a foreign currency put option to protect
1999 U.S. dollar results, with a strike price of $111 million and a cost of $4
million. At December 31, 1997, there were no foreign currency put options
outstanding.
The Company also has fixed the cost of certain employee benefit expenses
linked to its stock price by entering into equity swap and option contracts that
mature in 1999, 2002 and 2003. At December 31, 1998 and 1997, the notional
principal amounts of such contracts were $62 million and $53 million,
respectively, at a cost of $8 million each. The cost is amortized over the
duration of the contracts, and gains or losses are recognized as adjustments to
the carrying amount of the underlying liabilities.
In addition, the Company utilizes commodity swaps to fix the price on a
portion of certain raw materials used in the manufacturing process. As of
year-end 1998, $22 million of commodity swaps was outstanding, maturing through
December 1999. Such contracts at December 31, 1997, amounted to $31 million. The
maturity of the contracts highly correlates to the actual purchases of the
commodity, and contract values are reflected in the cost of the commodity as it
is actually purchased.
The above amounts exclude the swap and forward agreements described in the
Debt note, as well as the equity put options associated with the share
repurchase program, which are described separately in the Notes.
Several major international financial institutions are counterparties to
the Company's financial instruments. It is Company practice to monitor the
financial standing of the counterparties and to limit the amount of exposure
with any one institution. The Company may be exposed to credit loss in the event
of nonperformance by the counterparties to these contracts, but does not
anticipate such nonperformance.
With respect to trade receivables, concentration of credit risk is limited,
due to the diverse geographic areas covered by Gillette operations. Any probable
bad debt loss has been provided for in the allowance for doubtful accounts.
The estimated fair values of the Company's financial instruments are
summarized below.
Carrying Estimated
(Millions of dollars) Amount Fair Value
==================================== ========== ===========
DECEMBER 31, 1998
Long-term investments............... $ 177 $ 177
Total long-term debt................ (2,265) (2,277)
Foreign currency, interest rate
and commodity contracts............ 11 16
Equity contracts.................... 15 10
DECEMBER 31, 1997
Long-term investments............... $ 146 $ 148
Total long-term debt................ (1,485) (1,485)
Foreign currency, interest rate
and commodity contracts............ 70 65
Equity contracts.................... 28 28
The carrying amounts for cash, short-term investments, receivables,
accounts payable and accrued liabilities, and loans payable approximate fair
value because of the short maturity of these instruments. The fair value of
long-term investments is estimated based on quoted market prices. The fair value
of long-term debt, including the current portion, is estimated based on current
rates offered to the Company for debt of the same remaining maturities. The fair
value of foreign currency, interest rate, equity and commodity contracts is
estimated based on dealer quotes. These values represent the estimated amounts
the Company would receive or pay to terminate agreements, taking into
consideration current market rates and the current credit-worthiness of the
counterparties.
PAGE 31
28
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
CONTINGENCIES
The Company is subject to legal proceedings and claims arising out of its
business that cover a wide range of matters, including antitrust and trade
regulation, contracts, environmental issues, product liability, patent and
trademark matters and taxes.
Management, after review and consultation with counsel, considers that any
liability from all of these pending lawsuits and claims would not materially
affect the consolidated financial position, results of operations or liquidity
of the Company.
- --------------------------------------------------------------------------------
COMMITMENTS
Minimum rental commitments under noncancellable leases, primarily for office
and warehouse facilities, are $57 million in 1999, $46 million in 2000, $37
million in 2001, $31 million in 2002, $18 million in 2003 and $47 million for
years thereafter. Rental expense amounted to $103 million in 1998, $93 million
in 1997 and $93 million in 1996.
- --------------------------------------------------------------------------------
RESEARCH AND DEVELOPMENT
Research and development costs, included in selling, general and administrative
expenses, amounted to $209 million in 1998, $212 million in 1997 and $204
million in 1996.
- --------------------------------------------------------------------------------
MERGER-RELATED COSTS
In December 1996, Gillette completed a merger with Duracell International Inc.
In connection with the merger, the Company recorded a charge to operating
expenses of $413 million for direct and other merger-related costs pertaining to
the merger transaction and the combination of the worldwide businesses. In 1998,
the Company utilized the remaining $130 million from the reserve. All programs
were completed, and all program objectives were accomplished.
- --------------------------------------------------------------------------------
BUSINESS COMBINATIONS
AND DIVESTITURES
In 1998, the Company sold its Jafra skin care and color cosmetics business for
$200 million. The transaction did not have a material impact on financial
results.
Also during 1998, the Company acquired two businesses in the Duracell
segment, in South Korea and India, for an aggregate purchase price of $100
million. These two acquisitions have been accounted for by the purchase method
of accounting. Their results of operations since acquisition, which have been
included in the Company's consolidated financial statements in 1998, have not
materially affected the consolidated financial position, results of operations
or liquidity of the Company.
In 1997, the Company acquired an oral care business for $3 million.
- --------------------------------------------------------------------------------
REORGANIZATION AND REALIGNMENT
On September 28, 1998, the Company announced a reorganization that would realign
its worldwide operations. The reorganization includes formation of a new
management structure and the consolidation of business management and commercial
operations and related administrative functions. This will result in the closure
of 14 factories, 12 warehouses and 30 office facilities.
The program began in the fourth quarter of 1998, and will be implemented in
stages over an 18-month period. It will result in the reduction of approximately
4,700 employees across all business functions, business segments, geographic
areas and employee groups. Two manufacturing facilities were closed in 1998,
accounting for most of the 620 employee reductions in 1998.
In connection with the reorganization and realignment, and in accordance
with EITF issue 94-3 and SFAS 121, the Company recorded in the third quarter of
1998 a charge to operating expenses of $535 million ($347 million after taxes,
or $.30 in net income per common share, fully diluted). Employee severance and
related benefits, shown below, includes salary continuation, fringe benefits,
outplacement fees and special termination benefits related to pensions.
Details of the reorganization and realignment charges follow.
1998 Utilized
(Millions of dollars) Provision 1998 Balance
================================== ========= ======== =======
Employee severance and
related benefits .............. $385 $ 51 $334
Asset impairments ................ 135 135 --
Distributor buyout costs ......... 15 3 12
---- ---- ----
Total............................. $535 $189 $346
==== ==== ====
-------------------------------
The effect of suspending depreciation for impaired assets in the fourth
quarter was $3 million.
PAGE 32
29
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
INCOME TAXES
Deferred income taxes are recognized for the expected tax consequences of
temporary differences by applying enacted statutory tax rates, applicable to
future years, to differences between the financial reporting basis and tax basis
of assets and liabilities.
Income before income taxes and income tax expense are summarized below.
(Millions of dollars) 1998 1997 1996
================================== ====== ====== ======
Income before income taxes
United States ................... $1,026 $1,119 $ 880
Foreign ......................... 643 1,102 645
------ ------ ------
Total income before
income taxes .................... $1,669 $2,221 $1,525
====== ====== ======
Current tax expense
Federal ......................... $ 340 $ 247 $ 320
Foreign ......................... 330 311 307
State ........................... 58 59 67
Deferred tax expense
Federal ......................... (56) 77 (66)
Foreign ......................... (76) 87 (52)
State ........................... (8) 13 --
------ ------ ------
Total income tax expense ......... $ 588 $ 794 $ 576
======= ====== ======
A reconciliation of the statutory Federal income tax rates to the Company's
effective tax rate follows.
(Percent) 1998 1997 1996
======================================= ==== ==== ====
Statutory Federal tax rate............. 35.0% 35.0% 35.0%
Goodwill amortization.................. .3 .3 .3
Rate differential on
foreign income........................ 1.6 .4 --
Effect of foreign currency
translation........................... .2 .1 .2
State taxes (net of
Federal tax benefits)................. 1.9 2.1 2.6
Other differences...................... (3.7) (2.1) (1.7)
---- ---- ----
Effective tax rate before
merger-related costs.................. 35.3% 35.8% 36.4%
Merger-related costs................... -- -- 1.4
---- ---- ----
Effective tax rate..................... 35.3% 35.8% 37.8%
==== ==== ====
The components of deferred tax assets and deferred tax liabilities are
shown below.
1998 1997
---------------------- ---------------------
Deferred Deferred Deferred Deferred
Tax Tax Tax Tax
(Millions of dollars) Assets Liabilities Assets Liabilities
============================== ========== ============= ========== ============
CURRENT
Advertising and sales
promotion................... $ 23 $ -- $ 32 $ --
Benefit plans................ 81 -- 77 --
Merger-related costs and
certain realignment
programs.................... 161 -- 36 --
Miscellaneous reserves
and accruals................ 81 -- 91 --
Operating loss and credit
carryforwards............... 11 -- 7 --
Other........................ 160 -- 77 --
---- ---- ---- ----
Total current............... 517 $ -- 320 $ --
---- ==== ---- ====
Net current................. $517 $320
==== ====
NONCURRENT
Benefit plans................ $180 $ -- $163 $ --
Intangibles.................. -- 210 -- 230
Merger-related costs and
certain realignment
programs.................... 13 -- 12 --
Operating loss and credit
carryforwards............... 31 -- 33 --
Property, plant and
equipment................... -- 385 -- 246
Other........................ -- 11 -- 60
---- ---- ---- ----
Total noncurrent............ 224 606 208 536
---- ---- ---- ----
Valuation allowance.......... $(29) $(31)
==== ====
Net noncurrent............... $411 $359
==== ====
TOTAL
Net deferred tax assets/
liabilities................. $106 $ 39
==== ====
PAGE 33
30
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
PENSION PLANS AND OTHER RETIREE BENEFITS
The Company has various retirement programs, including defined benefit, defined
contribution and other plans, that cover most employees worldwide. In 1998, the
Company began funding its pension plans in Germany by contributing $252 million
to a newly established pension trust. Other retiree benefits are health care and
life insurance benefits provided to eligible retired employees, principally in
the United States. The components of benefit expense follow.
Pension Benefits Other Retiree Benefits
------------------------ ------------------------
(Millions of dollars) 1998 1997 1996 1998 1997 1996
============================================== ==== ====== ====== ==== ==== ====
COMPONENTS OF NET BENEFIT EXPENSE
Service cost-benefits earned ................ $ 67 $ 64 $ 61 $ 6 $ 5 $ 2
Interest cost on benefit obligation ......... 123 115 109 17 17 19
Estimated return on assets .................. (157) (118) (103) (3) (2) (2)
Net amortization ............................ 6 6 12 (7) (8) (3)
---- ---- ---- --- --- ---
39 67 79 13 12 16
Defined contribution plans .................. 2 4 4 -- -- --
Foreign plans not on SFAS 87 ................ 10 8 7 -- -- --
---- ---- ---- --- --- ---
Total benefit expense ........................ $ 51 $ 79 $ 90 $13 $12 $16
==== ==== ==== === === ===
The funded status of the Company's principal defined benefit and other
retiree benefit plans and the amounts recognized in the balance sheet at
December 31 follow.
Pension Benefits Other Retiree Benefits
---------------- ----------------------
(Millions of dollars) 1998 1997 1998 1997
======================================================================== ====== ====== ===== ======
CHANGE IN BENEFIT OBLIGATION:
Balance at beginning of year .......................................... $1,790 $1,689 $ 248 $ 266
Benefit payments ...................................................... (105) (83) (14) (13)
Service and interest costs ............................................ 191 179 23 22
Amendments ............................................................ 48 4 1 1
Actuarial (gains) losses .............................................. 88 52 (16) (28)
Currency translation adjustment ....................................... 10 (51) (2) --
------ ------ ----- ------
Balance at end of year ................................................ 2,022 1,790 240 248
CHANGE IN FAIR VALUE OF PLAN ASSETS:
Balance at beginning of year .......................................... 1,540 1,278 33 24
Actual return on plan assets .......................................... 204 272 6 6
Employer contribution ................................................. 299 57 (3) 3
Benefit payments ...................................................... (86) (69) -- --
Currency translation adjustment ....................................... -- 2 -- --
------ ------ ----- ------
Balance at end of year ................................................ 1,957 1,540 36 33
Plan assets less than benefit obligation ............................... (65) (250) (204) (215)
Unrecognized prior service cost and transition obligation .............. 57 36 (1) --
Unrecognized net loss (gain) ........................................... 54 17 (100) (87)
Minimum liability adjustment included in:
Intangible assets ..................................................... (17) (15) -- --
Stockholders' equity .................................................. (47) (20) -- --
------ ------ ----- ------
Net accrued benefit cost included in consolidated balance sheet ........ $ (18) $ (232) $(305) $ (302)
====== ====== ===== ======
PAGE 34
31
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
The values at December 31 for pension plans with accumulated benefit
obligations in excess of plan assets follow.
(Millions of dollars) 1998 1997
========================================= ==== ====
Projected benefit obligation............. $570 $506
Accumulated benefit obligation........... 506 429
Fair value of plan assets................ 304 30
The weighted average assumptions used in determining related obligations of
pension benefit plans are shown below.
(Percent) 1998 1997 1996
=============================================== ==== ==== ====
Discount rate.................................. 6.3 7.1 7.1
Long-term rate of return on assets............. 8.6 9.3 9.4
Rate of compensation increase.................. 3.9 4.9 4.8
The weighted average assumptions used in determining related obligations of
other retiree benefit plans are shown below.
(Percent) 1998 1997 1996
=============================================== ==== ==== ====
Discount rate.................................. 6.5 7.0 7.0
Long-term rate of return on assets............. 9.0 9.0 9.0
The assumed health care cost trend rate for 1999 is 6.5%, decreasing to
4.5% by 2001. A one percentage point increase in the trend rate would have
increased the accumulated postretirement benefit obligation by 12%, and interest
and service cost by 13%. A one percentage point decrease in the trend rate would
have decreased the accumulated postretirement benefit obligation by 10%, and
interest and service cost by 11%.
The Employee Stock Ownership Plan (ESOP) was established to assist
Gillette employees in financing retiree medical costs. ESOP shares allocated to
eligible participants reduce the Company's obligations over the period of
allocation. Account balances are assumed to have an annual yield of 12%. A
retiree health benefits account within the Company's principal domestic pension
plan will also be used to pay these costs.
- --------------------------------------------------------------------------------
EMPLOYEE STOCK OWNERSHIP PLAN
In 1990, the Company sold to the ESOP 165,872 shares of a new issue of 8%
cumulative Series C convertible preferred stock for $100 million, or $602.875
per share.
Each share of Series C stock is entitled to vote as if it were converted to
common stock and is convertible into 80 common shares at $7.53594 per share. At
December 31, 1998, 148,627 Series C shares were outstanding, of which 132,282
shares were allocated to employees and the remaining 16,345 shares were held in
the ESOP trust for future allocations. The 148,627 Series C shares are
equivalent to 11,890,147 shares of common stock, about 1.1% of the Company's
outstanding voting stock.
The Series C stock is redeemable upon the occurrence of certain change in
control or other events, at the option of the Company or the holder, depending
on the event, at varying prices not less than the purchase price plus accrued
dividends.
The ESOP purchased the Series C shares with borrowed funds guaranteed by
the Company. Gillette contributions to the ESOP and the dividends paid on the
Series C shares are used to pay loan principal and interest semiannually over a
10-year period.
As the ESOP loan is repaid, a corresponding amount of Series C stock held
in the trust is released to participant accounts. Allocations are made quarterly
to the accounts of eligible employees, generally on the basis of an equal amount
per participant. In general, regular U.S. employees participate in the ESOP
after completing one year of service with the Company.
The unpaid balance of this loan is reported as a liability of the Company.
An unearned ESOP compensation amount is reported as an offset to the Series C
shares in the equity section.
Plan costs and activity follow.
(Millions of dollars) 1998 1997 1996
============================================ ==== ==== ====
Compensation expense........................ $ 2 $ 3 $ 4
Cash contributions and dividends paid....... 10 11 13
Principal payments.......................... 9 9 10
Interest payments........................... 1 2 3
- --------------------------------------------------------------------------------
STOCK COMPENSATION PLANS
At December 31, 1998, the Company had stock-based compensation plans described
below that include the pre-merger plans of Duracell.
Stock option plans authorize the granting of options on shares of the
Company's common stock to selected key employees, including those who also may
be officers, and to nonemployee directors, at not less than the fair market
value of the stock on the date of grant. Outstanding options have seven- to
10-year terms.
Options granted prior to April 17, 1997, are exercisable one year from the
date of grant (except the Duracell options, which became exercisable upon the
merger), provided the employee optionee is still employed or the director
continues to serve. For options granted after
PAGE 35
32
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
April 16, 1997, one-third of the options become vested on each of the first
three anniversaries of the stock option award date. The plans also permit
payment for options exercised in shares of the Company's common stock (except
Duracell options) and the granting of incentive stock options.
The Company applied APB 25 and related interpretations in accounting for
its plans. Accordingly, no compensation cost has been recognized for its fixed
stock option plans in its results of operations. Had the Company recorded a
charge for the fair value of options granted consistent with SFAS 123, net
income would have been reduced by $100 million in 1998, $88 million in 1997 and
$47 million in 1996. The impact of this charge on net income per common share,
both basic and assuming full dilution, would have been $.09, $.08 and $.04 in
1998, 1997 and 1996, respectively.
The fair value of each option grant for the Company's plans is estimated on
the date of the grant using the Black-Scholes option pricing model, with the
following weighted average assumptions used for grants in 1998, 1997 and 1996.
1998 1997 1996*
========= ========= ==============
Risk-free interest rates .. 5.7% 6.6% 6.5/6.7%
Expected option lives ..... 4.5 years 4.6 years 4.6/7.0 years
Expected volatilities ..... 19.2% 19.2% 22.0/29.0%
Expected dividend yields .. .9% .9% 1.2/2.1%
* Gillette/Duracell
- --------------------------------------------------------------------------------
A summary of the status of the Company's stock option plans at December 31,
1998, 1997 and 1996 follows.
1998 1997 1996
-------------------------- ------------------------- --------------------------
Weighted Average Weighted Average Weighted Average
(Thousands of shares) Shares Exercise Price Shares Exercise Price Shares Exercise Price
======================================= ======= ================ ====== ================ ======= ================
Outstanding at beginning of year* ..... 38,828 $ 27.18 38,536 $18.71 41,500 $14.80
Granted ............................... 10,984 56.29 10,586 47.15 8,918 29.01
Exercised ............................. (5,635) 17.53 (10,094) 15.59 (9,966) 13.16
Cancelled ............................. (518) 48.59 (200) 37.49 (986) 20.49
------ ------ ------
Outstanding at year-end* .............. 43,659 35.49 38,828 27.18 39,466 18.29
====== ====== ======
Options exercisable at year-end ....... 26,321 28,334 31,410
====== ====== ======
Weighted average fair value of options
granted during the year .............. $14.12 $12.92 $ 8.39
* Options outstanding at year-end 1996 include 9,710 pre-merger Duracell
options. Options outstanding at the beginning of 1997 reflect the
conversion of each Duracell option to .904 of a Gillette option.
The following table summarizes information about fixed stock options
outstanding at December 31, 1998.
Options Outstanding Options Exercisable
---------------------------------------------------------- ---------------------------------
Number Weighted Average Number
Outstanding Remaining Years Weighted Average Exercisable Weighted Average
Range of Exercise Prices (Thousands) of Contractual Life Exercise Price (Thousands) Exercise Price
========================== ============= ===================== ================== ============= =================
$ 3- 9.................... 1,455 2.0 $ 8 1,455 $ 8
11-14 ................... 3,334 4.1 12 3,334 12
16-21 ................... 10,997 5.2 19 10,997 19
21-26 ................... 378 3.0 24 378 24
27-30 ................... 6,571 7.5 29 6,571 29
35-48 ................... 10,049 8.5 47 3,586 47
50-60 ................... 10,875 9.5 56 --
------ ------
$ 3-60.................... 43,659 7.1 $35 26,321 $24
====== ======
PAGE 36
33
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
Eligible Gillette employees participate in the Stock Equivalent Unit Plan,
which provides for awards of basic stock units to key employees, although awards
have not been made to executive officers since 1990. Each unit is treated as
equivalent to one share of the Company's common stock. However, the employee
only receives appreciation, if any, in the market value of the stock and
dividend equivalent units as dividends are paid. Appreciation on basic stock
units is limited to 100% of the original market value. Benefits accrue over
seven years, and vesting commences in the third year. Plan expense amounted to
$9 million in 1998, $21 million in 1997 and $23 million in 1996.
- --------------------------------------------------------------------------------
SHARE REPURCHASE PROGRAM
On September 18, 1997, the Company's Board of Directors authorized a share
repurchase program to purchase up to 50 million shares in the open market or in
privately negotiated transactions, depending on market conditions and other
factors. The Company repurchased 21 million shares in the open market for $1,066
million in 1998. Since the inception of the program, the Company has repurchased
22 million shares in the open market for $1,119 million.
During 1997 and 1998, the Company sold equity put options as an enhancement
to its ongoing share repurchase program and collected $83 million in premiums.
These options provide the Company with an additional source to supplement
open-market purchases of its common stock. The option prices were based on the
market value of the Company's stock at the date of issuance. The redemption
value of the outstanding options, which represents the options' price multiplied
by the number of shares under option, is presented in the accompanying
consolidated balance sheet as "Contingent Redemption Value of Common Stock Put
Options." At December 31, 1998 and 1997, no shares of outstanding common stock
were subject to repurchase under the terms and conditions of these options.
- --------------------------------------------------------------------------------
PREFERRED STOCK PURCHASE RIGHTS
At December 31, 1998, the Company had 1,117,296,898 preferred stock purchase
rights outstanding as follows: one right for each share of common stock
outstanding and a total of 11,890,147 rights for the outstanding Series C
preferred stock. Each right may be exercised to purchase one ten-thousandth of a
share of junior participating preferred stock for $225. The rights will only
become exercisable, or separately transferable, on the earlier of the tenth
business day after the Company announces that a person has acquired 15% or more,
or the tenth business day after a tender offer commences that could result in
ownership of more than 15%, of the Company's common stock.
If any person acquires 15% or more of the common stock (except in an offer
for all common stock that has been approved by the Board of Directors), or in
the event of certain mergers or other transactions involving a 15% or more
stockholder, each right not owned by that person or related parties will enable
its holder to purchase, at the right's exercise price, common stock (or a
combination of common stock and other assets) having double that value. In the
event of certain merger or asset sale transactions with another party, similar
terms would apply to the purchase of that party's common stock.
The rights, which have no voting power, expire on December 14, 2005,
subject to extension. Upon approval by the Board of Directors, the rights may be
redeemed for $.01 each under certain conditions, which may change after any
person becomes a 15% stockholder.
At December 31, 1998, there were authorized 5,000,000 shares of preferred
stock without par value, of which 148,627 Series C shares were issued and
outstanding and 400,000 Series A shares were reserved for issuance upon exercise
of the rights.
PAGE 37
34
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
OPERATING SEGMENTS AND RELATED INFORMATION
The following table presents certain operating segment information.
(Millions of dollars) Blades & Toiletries Stationery Braun Oral-B Duracell All
1998 Razors Products Products Products Products Other Total
=============================== ======== ========== ========== ======== ======== ======== ===== =======
Net sales ................... $3,028 $1,214 $ 856 $1,740 $642 $2,576 $ -- $10,056
Profit from operations ........ 1,153 54 108 291 101 597 (515) 1,789
Identifiable assets ........... 3,378 771 1,330 1,679 680 3,288 776 11,902
Capital expenditures .......... 453 69 48 135 62 144 89 1,000
Depreciation .................. 167 27 24 73 18 51 13 373
------ ------ ------ ------ ---- ------ ---- -------
1997
- ----
Net sales ................... $2,881 $1,410 $ 924 $1,744 $624 $2,478 $ 1 $10,062
Profit from operations ........ 1,186 124 156 304 85 526 (57) 2,324
Identifiable assets ........... 3,006 1,004 1,299 1,544 622 3,138 251 10,864
Capital expenditures .......... 423 88 40 126 45 165 86 973
Depreciation .................. 111 37 23 77 17 58 7 330
------ ------ ------ ------ ---- ------ ---- -------
996
- ----
Net sales ................... $2,836 $1,375 $ 915 $1,773 $547 $2,251 $ 1 $ 9,698
Profit from operations ........ 1,098 91 122 300 58 450 (483) 1,636
Identifiable assets ........... 2,591 874 1,244 1,534 595 3,154 423 10,415
Capital expenditures .......... 353 65 43 120 38 201 10 830
Depreciation .................. 96 26 20 78 15 51 7 293
- ------------------------------- ====== ====== ====== ====== ==== ====== ==== =======
Each operating segment is individually managed and has separate financial
results that are reviewed by the Company's chief operating decision-makers. Each
segment contains closely related products that are unique to the particular
segment.
The principal products included in each of the Company's operating segments
are described in the review of operations, which appears earlier.
Profit from operations is net sales less cost of sales and selling, general
and administrative expenses, but is not affected either by nonoperating
charges/income or by income taxes.
Nonoperating charges/income consists principally of net interest expense
and the effect of exchange.
In calculating profit from operations for individual operating segments,
substantial administrative expenses incurred at the operating level that are
common to more than one segment are allocated on a net sales basis. Certain
headquarters expenses of an operational nature also are allocated to segments
and geographic areas.
All intercompany transactions have been eliminated, and intersegment
revenues are not significant.
The $535 million charge to profit from operations in 1998 for
reorganization and realignment is not assigned to the operating segments in the
accompanying table, since the elements of the charge are managed separately from
the segments.
Had the Company allocated the charge by segment, the amounts would have
been as follows: Blades & Razors, $117 million; Toiletries, $47 million;
Stationery Products, $95 million; Braun Products, $69 million; Oral-B Products,
$68 million; Duracell Products, $128 million; and All Other, $11 million.
Profit from operations in 1996 has been restated for SFAS 131. The $413
million charge for merger-related costs is now included in All Other. The charge
was previously reported by segment as follows: Blades & Razors, $36 million;
Toiletries, $4 million; Duracell Products, $308 million; and All Other, $65
million.
PAGE 38
35
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
The All Other column includes items not allocated to operating segments.
Profit from operations includes the $535 million charge for reorganization and
realignment in 1998, the $413 million charge for merger-related costs in 1996
and all unallocated income/expense items, including corporate headquarters
expenses. Identifiable assets includes deferred income tax assets, nonqualified
benefit trusts, construction-in-progress costs related to Corporate Information
Technology initiatives and other financial instruments managed by the Corporate
Treasury Department. Capital expenditures is primarily related to Corporate
Information Technology initiatives.
Net sales by geographic area follow.
(Millions of dollars) 1998 1997 1996
========================== ======= ======= ======
Foreign................... $ 6,241 $ 6,380 $6,117
United States............. 3,815 3,682 3,581
------- ------- ------
$10,056 $10,062 $9,698
======= ======= ======
Long-lived assets at December 31 follow.
==========================================================
Germany.................. $ 575 $ 438 $ 426
Other Foreign............ 1,261 1,202 1,030
------ ------ ------
Total Foreign............ 1,836 1,640 1,456
United States............ 1,636 1,464 1,130
------ ------ ------
$3,472 $3,104 $2,586
====== ====== ======
INDEPENDENT AUDITORS' REPORT
[KPMG Logo]
- --------------------------------------------------------------------------------
THE STOCKHOLDERS AND BOARD OF DIRECTORS OF THE GILLETTE COMPANY
We have audited the accompanying consolidated balance sheet of The Gillette
Company and subsidiary companies as of December 31, 1998 and 1997, and the
related consolidated statements of income, cash flows and stockholders' equity
for each of the years in the three-year period ended December 31, 1998. These
consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these consolidated
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of The Gillette
Company and subsidiary companies at December 31, 1998 and 1997, and the results
of their operations and their cash flows for each of the years in the three-year
period ended December 31, 1998, in conformity with generally accepted accounting
principles.
KPMG Peat Marwick LLP
Boston, Massachusetts
February 11, 1999
PAGE 39
36
The Gillette Company and Subsidiary Companies
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
Three Months Ended
(Millions of dollars, except per share amounts) ----------------------------------------------------
1998* March 31 June 30 September 30 December 31 Total Year
========================================================== ======== ======= ============ =========== ===========
Net sales................................................. $2,025 $2,325 $2,531 $ 3,175 $10,056
Gross profit.............................................. 1,242 1,443 1,557 1,961 6,203
Profit from operations.................................... 434 595 40 720 1,789
Income before income taxes................................ 414 575 9 671 1,669
Net income................................................ 268 372 6 435 1,081
Net income per common share, basic........................ .24 .33 -- .39 .96
Net income per common share, assuming full dilution....... .23 .33 -- .39 .95
Dividends declared per common share....................... -- .12 3/4 .12 3/4 .25 1/2 .51
Stock price range: (composite basis)
High..................................................... 61.09 62.66 62.56 49.38 62.66
Low...................................................... 48.59 54.75 35.31 37.06 35.31
1997 (Recast)**
========================================================== ======== ======= ============ =========== ===========
Net sales................................................. $1,999 $2,366 $2,701 $ 2,996 $10,062
Gross profit.............................................. 1,249 1,443 1,668 1,871 6,231
Profit from operations.................................... 388 549 702 685 2,324
Income before income taxes................................ 367 523 680 651 2,221
Net income................................................ 236 336 437 418 1,427
Net income per common share, basic........................ .21 .30 .39 .37 1.27
Net income per common share, assuming full dilution....... .21 .29 .38 .36 1.24
1997 (Previously Reported)
========================================================== ======== ======= ============ =========== ===========
Net sales................................................. $2,180 $2,285 $2,437 $ 3,160 $10,062
Gross profit.............................................. 1,355 1,426 1,507 1,943 6,231
Profit from operations.................................... 466 518 575 765 2,324
Income before income taxes................................ 442 496 550 733 2,221
Net income................................................ 283 319 354 471 1,427
Net income per common share, basic........................ .25 .29 .31 .42 1.27
Net income per common share, assuming full dilution....... .25 .28 .30 .41 1.24
Dividends declared per common share....................... -- .10 3/4 .10 3/4 .21 1/2 .43
Stock price range: (composite basis)
High..................................................... 43.06 49.81 53.19 51.16 53.19
Low...................................................... 36.00 36.13 38.94 41.94 36.00
=============================================================================================================================
- ------------------------------------------------------------------------
* In the third quarter of 1998, a charge for reorganization and realignment
expenses reduced profit from operations and income before income taxes by
$535 million, net income by $347 million, basic net income per share by
$.31 and net income per share, assuming full dilution, by $.30.
** Quarterly financial information has been recast to reflect the
harmonization of operating groups on a common calendar year basis.
PAGE 40
37
The Gillette Company and Subsidiary Companies
HISTORICAL FINANCIAL SUMMARY
- --------------------------------------------------------------------------------
HISTORICAL FINANCIAL SUMMARY
(In millions, except per share amounts, stock prices and employees)
Net Income
Per Common Share
------------------- Average
Profit Income Assuming Common
Net from before Net Full Shares Year-end
Year Sales Operations Taxes Income Basic Dilution Outstanding Stock Price
============= ======= ========== ======== ====== ===== ======== =========== ============
1998(a) $10,056 $1,789 $1,669 $1,081 $ .96 $ .95 1,117 $47.81
1997 10,062 2,324 2,221 1,427 1.27 1.24 1,118 50.22
- ----- ------- ------ ------ ------ ----- ----- ----- ------
1996(b) 9,698 1,636 1,525 949 .85 .83 1,107 38.88
1995 8,834 1,799 1,700 1,069 .97 .95 1,100 26.06
1994 7,935 1,615 1,458 919 .83 .82 1,096 18.72
1993(c) 7,085 1,091 907 421 .38 .37 1,090 14.91
1992(d) 6,752 1,263 1,061 601 .55 1,082 14.22
1991(d) 6,188 1,144 844 432 .41 1,018 14.03
1990(d) 5,709 1,020 633 382 .36 906 7.84
===== ======= ====== ====== ====== ===== ===== ======
Dividends Declared
Net Depreciation Net Property, Per Common Share
Interest and Capital Plant and Total Long-term Stockholders' -------------------
Year Expense Amortization Expenditures Equipment Assets Debt Equity Gillette Duracell Employees
==== ========= ============ ============ ============= ======= ========== ============= ======== ======== =========
1998 $ 86 $459 $1,000 $3,472 $11,902 $2,256 $4,543 $.51 43,100
1997 69 422 973 3,104 10,864 1,476 4,841 .43 44,000
- ---- ---- ---- ------ ------ ------- ------ ------ ----- ------
1996 67 381 830 2,586 10,415 1,490 4,471 .36 $.58 44,100
1995 73 343 593 2,053 8,918 1,048 3,879 .30 .52 41,900
1994 68 303 498 1,750 7,766 1,073 3,257 .25 .44 40,700
1993 66 303 396 1,507 7,116 1,234 2,582 .21 .32 41,000
1992 114 298 370 1,396 6,400 1,124 2,538 .18 .08 38,800
1991 225 277 339 1,262 6,169 1,473 2,134 .155 -- 39,200
1990 319 259 285 1,183 5,921 2,456 607 .135 -- 38,300
==== ==== ==== ====== ====== ======= ====== ====== ===== ==== ======
Per common share amounts, shares outstanding and stock prices have been restated
to reflect two-for-one stock splits in 1998, 1995 and 1991.
(a) In 1998, a charge for reorganization and realignment expenses reduced profit
from operations and income before income taxes by $535 million, net income by
$347 million, basic net income per common share by $.31 and net income per
common share, assuming full dilution, by $.30.
(b) In 1996, charges for merger-related costs reduced profit from operations and
income before income taxes by $413 million, net income by $283 million, basic
net income per common share by $.26 and net income per common share, assuming
full dilution, by $.25.
(c) In 1993, charges for realignment and restructuring expenses reduced profit
from operations and income before income taxes by $328 million, net income by
$212 million, basic net income per common share by $.19 and net income per
common share, assuming full dilution, by $.19. In addition, in 1993, the
cumulative effect of adopting mandated changes in the methods of accounting for
income taxes, postretirement benefits and postemployment benefits reduced net
income by $139 million and net income per common share, basic and assuming full
dilution, by $.13 and $.12, respectively.
(d) Charges for extraordinary items reduced net income by $75 million in 1992,
$109 million in 1991 and $6 million in 1990 and basic net income per common
share by $.07 in 1992, $.11 in 1991 and $.01 in 1990.
PAGE 41
38
CORPORATE AND STOCKHOLDER INFORMATION
- -------------------------------------------------------------------------------
ANNUAL MEETING
The Annual Meeting of stockholders will take place on Thursday, April 15, 1999,
at the John F. Kennedy Library and Museum, Columbia Point, Boston,
Massachusetts. The meeting will convene at 10 a.m.
- -------------------------------------------------------------------------------
CORPORATE HEADQUARTERS
Prudential Tower Building
Boston, Massachusetts 02199
(617)421-7000
World Wide Web users can access Gillette information at http://www.gillette.com,
the Company's Internet site.
- -------------------------------------------------------------------------------
INCORPORATED
State of Delaware
- -------------------------------------------------------------------------------
COMMON STOCK
Major stock exchanges: New York, Boston, Chicago, Pacific, Frankfurt
New York Stock Exchange Symbol: G
At year-end, stockholders numbered 61,500, living in all 50 states and more than
30 countries abroad.
- -------------------------------------------------------------------------------
TRANSFER AGENT AND REGISTRAR
BankBoston, N.A.
c/o EquiServe L.P.
P.O. Box 8040
Boston, Massachusetts 02266-8040
(781) 575-2322
By fax: (781)828-8813
Toll-free: (888) 218-2841
Hearing impaired: (800) 952-9245 (TTY/TDD)
Via Internet: http://www.EQUISERVE.com
- -------------------------------------------------------------------------------
AUDITORS
KPMG
- -------------------------------------------------------------------------------
FORM 10-K
The Company's 1998 Annual Report on Form 10-K, filed with the Securities and
Exchange Commission, will be available in late March without charge from the
Office of the Secretary by written request, or by calling toll-free
(800)291-7615. The report also will be available at http://www.gillette.com, the
Company's Internet site.
- -------------------------------------------------------------------------------
INVESTLINK(SM) -- DIRECT STOCK PURCHASE PROGRAM
InvestLink(SM) is a direct stock purchase program designed to promote long-term
ownership among investors who are committed to investing a minimum amount and
building their Gillette share ownership over time. The program is sponsored and
administered by BankBoston, N.A., the Company's transfer agent. InvestLink(SM)
provides an economical, convenient way to purchase your first shares or to
purchase additional shares of Gillette common stock directly from the Company.
Program participants may also reinvest their cash dividends through
InvestLink(SM). You may request an enrollment application and a brochure from:
BankBoston, N.A.
"InvestLink" Program
P.O.Box 8040
Boston, Massachusetts 02266-8040
(781) 575-2322
Toll-free: (800) 643-6989
Hearing impaired: (800) 952-9245 (TTY/TDD)
- -------------------------------------------------------------------------------
QUARTERLY REPORTS
The Company mails quarterly reports only to registered holders of Gillette
common stock. If your shares are registered in the name of a broker or other
nominee, and you would like to receive the quarterly reports, the Company will
gladly mail them directly to you. You may add your name to our mailing list by
writing to the Office of the Secretary, or by calling toll-free (800) 291-7615.
Gillette quarterly reports also are available at http://www.gillette.com,
the Company's Internet site.